| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cyclase activity | 1.16e-12 | 24 | 204 | 9 | GO:0009975 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 1.80e-12 | 25 | 204 | 9 | GO:0016849 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 4.15e-12 | 18 | 204 | 8 | GO:0004016 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1B2 HSP90B1 ABCC4 MYH8 ABCA1 MYH10 ERCC3 MYO1A ERCC6L CFTR MCM4 ABCA8 SHPRH HELZ DNAH8 DNAH10 DYNC2H1 DHX37 CECR2 MYO1B RFC1 SLFN13 DDX53 SLFN11 POLQ YME1L1 SNRNP200 | 1.79e-10 | 614 | 204 | 27 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | HSP90B1 ABCC4 MYH8 ABCA1 ERCC3 ERCC6L CFTR MCM4 ABCA8 DNAH8 DNAH10 DYNC2H1 DHX37 RFC1 SLFN13 DDX53 SLFN11 POLQ YME1L1 SNRNP200 | 2.90e-08 | 441 | 204 | 20 | GO:0016887 |
| GeneOntologyMolecularFunction | calcium- and calmodulin-responsive adenylate cyclase activity | 5.25e-08 | 5 | 204 | 4 | GO:0008294 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | NUGGC HSP90B1 ABCC4 MYH8 ABCA1 ERCC3 ERCC6L CFTR MCM4 ABCA8 RRAGC RAB3A RAB3B DNAH8 RAC1 DNAH10 DYNC2H1 DHX37 RAB3D RFC1 SLFN13 DDX53 SLFN11 POLQ YME1L1 SNRNP200 | 1.03e-07 | 775 | 204 | 26 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | NUGGC HSP90B1 ABCC4 MYH8 ABCA1 ERCC3 ERCC6L CFTR MCM4 ABCA8 RRAGC RAB3A RAB3B DNAH8 RAC1 DNAH10 DYNC2H1 DHX37 RAB3D RFC1 SLFN13 DDX53 SLFN11 POLQ YME1L1 SNRNP200 | 4.76e-07 | 839 | 204 | 26 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | NUGGC HSP90B1 ABCC4 MYH8 ABCA1 ERCC3 ERCC6L CFTR MCM4 ABCA8 RRAGC RAB3A RAB3B DNAH8 RAC1 DNAH10 DYNC2H1 DHX37 RAB3D RFC1 SLFN13 DDX53 SLFN11 POLQ YME1L1 SNRNP200 | 4.87e-07 | 840 | 204 | 26 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | NUGGC HSP90B1 ABCC4 MYH8 ABCA1 ERCC3 ERCC6L CFTR MCM4 ABCA8 RRAGC RAB3A RAB3B DNAH8 RAC1 DNAH10 DYNC2H1 DHX37 RAB3D RFC1 SLFN13 DDX53 SLFN11 POLQ YME1L1 SNRNP200 | 4.87e-07 | 840 | 204 | 26 | GO:0016818 |
| GeneOntologyMolecularFunction | actin filament binding | MYH8 MYH10 MYO1A ANXA8L1 MPRIP SYNE1 CAPG MYO1B ANXA8 ARPC3 GSN MYO16 | 3.99e-06 | 227 | 204 | 12 | GO:0051015 |
| GeneOntologyMolecularFunction | helicase activity | ERCC3 ERCC6L MCM4 SHPRH HELZ DHX37 DDX53 SLFN11 POLQ SNRNP200 | 5.35e-06 | 158 | 204 | 10 | GO:0004386 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.90e-05 | 118 | 204 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | lyase activity | ADCY1 ADCY2 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 GUCY1B2 GUCY1B1 POLQ | 6.77e-05 | 212 | 204 | 10 | GO:0016829 |
| GeneOntologyMolecularFunction | GTP-dependent protein binding | 9.58e-05 | 24 | 204 | 4 | GO:0030742 | |
| GeneOntologyMolecularFunction | actin binding | MYH8 MYH10 MYO1A ANXA8L1 ADCY8 MPRIP DST NOS3 SYNE1 CAPG MYO1B ANXA8 ARPC3 GSN MYO16 | 1.27e-04 | 479 | 204 | 15 | GO:0003779 |
| GeneOntologyMolecularFunction | calmodulin binding | 1.33e-04 | 230 | 204 | 10 | GO:0005516 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 2.21e-04 | 84 | 204 | 6 | GO:0003684 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.33e-04 | 127 | 204 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERCC3 ERCC6L EARS2 MCM4 SHPRH HELZ DCLRE1A DHX37 POLD1 CECR2 RFC1 METTL4 SLFN13 DDX53 SLFN11 POLQ SNRNP200 | 3.53e-04 | 645 | 204 | 17 | GO:0140640 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERCC3 ERCC6L MCM4 SHPRH DCLRE1A POLD1 CECR2 RFC1 METTL4 POLQ | 3.78e-04 | 262 | 204 | 10 | GO:0140097 |
| GeneOntologyMolecularFunction | microfilament motor activity | 5.95e-04 | 38 | 204 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 7.66e-04 | 18 | 204 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATPase binding | 8.52e-04 | 108 | 204 | 6 | GO:0051117 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | GPHN MYH8 MYH10 MYO1A ANXA8L1 ADCY8 MPRIP DST MID1 RAB3A RAB3B NOS3 DIP2B SYNE1 IFT81 CAPG RAB3D DPYSL4 MYO1B ANXA8 ARPC3 GSN MYO16 | 8.85e-04 | 1099 | 204 | 23 | GO:0008092 |
| GeneOntologyMolecularFunction | apolipoprotein A-I binding | 1.02e-03 | 5 | 204 | 2 | GO:0034186 | |
| GeneOntologyMolecularFunction | guanine nucleotide transmembrane transporter activity | 1.02e-03 | 5 | 204 | 2 | GO:0001409 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 1.02e-03 | 5 | 204 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | myosin V binding | 1.05e-03 | 20 | 204 | 3 | GO:0031489 | |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 1.14e-03 | 45 | 204 | 4 | GO:0043495 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC46A2 ATP6V1B2 ABCC4 ABCA1 SLC6A17 CFTR ABCA8 SLC25A24 SLC25A18 SLC6A16 SLC26A9 SLC6A15 SLC6A8 | 1.30e-03 | 477 | 204 | 13 | GO:0022804 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.56e-03 | 49 | 204 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 1.56e-03 | 49 | 204 | 4 | GO:0005547 | |
| GeneOntologyMolecularFunction | myosin binding | 1.79e-03 | 85 | 204 | 5 | GO:0017022 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.92e-03 | 171 | 204 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | GDP-dissociation inhibitor binding | 2.11e-03 | 7 | 204 | 2 | GO:0051021 | |
| GeneOntologyBiologicalProcess | cAMP biosynthetic process | 2.57e-12 | 11 | 203 | 7 | GO:0006171 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 3.31e-11 | 23 | 203 | 8 | GO:0009190 | |
| GeneOntologyBiologicalProcess | cAMP metabolic process | 3.34e-09 | 25 | 203 | 7 | GO:0046058 | |
| GeneOntologyBiologicalProcess | cyclic purine nucleotide metabolic process | 1.00e-08 | 44 | 203 | 8 | GO:0052652 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide metabolic process | 1.21e-08 | 45 | 203 | 8 | GO:0009187 | |
| GeneOntologyBiologicalProcess | cellular response to forskolin | 1.42e-08 | 18 | 203 | 6 | GO:1904322 | |
| GeneOntologyBiologicalProcess | response to forskolin | 2.06e-08 | 19 | 203 | 6 | GO:1904321 | |
| GeneOntologyBiologicalProcess | cell projection assembly | ABCC4 MYH10 MYO1A SRC SRF RO60 ODAD4 TENM2 FSIP2 AKAP4 AKT1 VAV3 DNAH8 RAC1 DYNC2H1 SYNE1 IFT81 CAPG GSN BBS10 DNAI4 | 4.35e-06 | 685 | 203 | 21 | GO:0030031 |
| GeneOntologyBiologicalProcess | cellular response to alcohol | 5.72e-06 | 130 | 203 | 9 | GO:0097306 | |
| GeneOntologyBiologicalProcess | cellular response to ketone | 5.72e-06 | 130 | 203 | 9 | GO:1901655 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | ABCC4 MYH10 MYO1A SRF RO60 ODAD4 TENM2 FSIP2 AKAP4 AKT1 VAV3 DNAH8 RAC1 DYNC2H1 SYNE1 IFT81 GSN BBS10 DNAI4 | 3.71e-05 | 670 | 203 | 19 | GO:0120031 |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 6.97e-05 | 178 | 203 | 9 | GO:0006261 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in cell | 1.04e-04 | 76 | 203 | 6 | GO:0032507 | |
| GeneOntologyBiologicalProcess | wound healing | NRG1 MYH10 EPPK1 ANXA8L1 SRC SRF DGKA JAK2 DST VAV3 RAB3A NOS3 ANXA8 SCARB1 SERPINC1 | 1.16e-04 | 493 | 203 | 15 | GO:0042060 |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 1.20e-04 | 191 | 203 | 9 | GO:0007189 | |
| GeneOntologyBiologicalProcess | skeletal muscle cell proliferation | 1.78e-04 | 29 | 203 | 4 | GO:0014856 | |
| GeneOntologyBiologicalProcess | positive regulation of TORC1 signaling | 2.23e-04 | 56 | 203 | 5 | GO:1904263 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 2.33e-04 | 31 | 203 | 4 | GO:0098974 | |
| GeneOntologyBiologicalProcess | cilium organization | ABCC4 RO60 ODAD4 TUB FSIP2 AKAP4 AKT1 DNAH8 DYNC2H1 SYNE1 IFT81 GSN BBS10 DNAI4 | 2.78e-04 | 476 | 203 | 14 | GO:0044782 |
| GeneOntologyBiologicalProcess | DNA replication | NUGGC MCM4 PURA RAC1 MMS22L ACTR8 POLD1 RFC1 METTL4 SLFN11 POLQ | 2.79e-04 | 312 | 203 | 11 | GO:0006260 |
| GeneOntologyBiologicalProcess | peptidyl-cysteine methylation | 2.87e-04 | 3 | 203 | 2 | GO:0018125 | |
| GeneOntologyBiologicalProcess | negative regulation of phospholipase A2 activity | 2.87e-04 | 3 | 203 | 2 | GO:1900138 | |
| GeneOntologyBiologicalProcess | nuclear matrix anchoring at nuclear membrane | 2.87e-04 | 3 | 203 | 2 | GO:0090292 | |
| GeneOntologyCellularComponent | glutamatergic synapse | NRG1 MYH10 SLC6A17 SRC ADGRB1 TENM2 ADCY1 ADCY8 JAK2 PURA AKT1 RAC1 CALB1 TPRG1L EGLN1 ANO1 ALS2 SLC6A8 TENM3 GUCY1B1 ROBO2 | 6.54e-05 | 817 | 207 | 21 | GO:0098978 |
| GeneOntologyCellularComponent | postsynapse | GPHN NRG1 RPL30 MYH10 SLC6A17 SRC ADGRB1 TENM2 ADCY1 ADCY8 JAK2 DST PURA SORCS2 AKT1 RAB3A RAC1 CALB1 SYNE1 EGLN1 ALS2 SLC6A8 P2RX3 ROBO2 | 7.52e-05 | 1018 | 207 | 24 | GO:0098794 |
| GeneOntologyCellularComponent | actin-based cell projection | ATP6V1B2 MYO1A CFTR SRC TENM2 ADCY6 CBLIF CALB1 MYO1B LOXHD1 SCARB1 | 1.08e-04 | 278 | 207 | 11 | GO:0098858 |
| GeneOntologyCellularComponent | cell-substrate junction | RPL30 HSP90B1 EPPK1 ITGB1BP1 SRC ADGRB1 MPRIP JAK2 DST RAC1 FLT1 ARPC3 GSN IGF2R | 1.42e-04 | 443 | 207 | 14 | GO:0030055 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH8 MYH10 MYO1A SRC POTEKP ADCY8 MPRIP DST RAC1 FLT1 CALB1 CAPG MYO1B ARPC3 GSN MYO16 | 2.11e-04 | 576 | 207 | 16 | GO:0015629 |
| GeneOntologyCellularComponent | microvillus | 2.27e-04 | 123 | 207 | 7 | GO:0005902 | |
| GeneOntologyCellularComponent | sperm end piece | 2.91e-04 | 3 | 207 | 2 | GO:0097229 | |
| GeneOntologyCellularComponent | basal ectoplasmic specialization | 2.91e-04 | 3 | 207 | 2 | GO:0061832 | |
| GeneOntologyCellularComponent | myosin complex | 2.94e-04 | 59 | 207 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | focal adhesion | RPL30 HSP90B1 ITGB1BP1 SRC ADGRB1 MPRIP JAK2 DST RAC1 FLT1 ARPC3 GSN IGF2R | 3.84e-04 | 431 | 207 | 13 | GO:0005925 |
| GeneOntologyCellularComponent | site of DNA damage | 4.38e-04 | 137 | 207 | 7 | GO:0090734 | |
| GeneOntologyCellularComponent | cell leading edge | ATP6V1B2 MYH10 MYO1A ITGB1BP1 SRC DST AKT1 RAC1 CAPG ALS2 ARPC3 GSN ARPIN ROBO2 | 4.85e-04 | 500 | 207 | 14 | GO:0031252 |
| GeneOntologyCellularComponent | lamellipodium | 4.96e-04 | 230 | 207 | 9 | GO:0030027 | |
| GeneOntologyCellularComponent | presynaptic active zone | 5.21e-04 | 141 | 207 | 7 | GO:0048786 | |
| GeneOntologyCellularComponent | axon | NRG1 MYH10 MYO1A SRC POTEKP TENM2 ADCY8 ADCY9 DST RAB3A DIP2B CALB1 TPRG1L ALS2 RET ARPC3 P2RX3 TENM3 ROBO2 WDFY3 | 5.71e-04 | 891 | 207 | 20 | GO:0030424 |
| GeneOntologyCellularComponent | guanylate cyclase complex, soluble | 5.78e-04 | 4 | 207 | 2 | GO:0008074 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 6.67e-04 | 147 | 207 | 7 | GO:0030665 | |
| GeneOntologyCellularComponent | dendritic spine | 7.14e-04 | 242 | 207 | 9 | GO:0043197 | |
| GeneOntologyCellularComponent | synaptic membrane | GPHN NRG1 SRC ADGRB1 TENM2 ADCY1 ADCY8 SORCS2 RAC1 SYNE1 ANO1 SLC6A8 P2RX3 TENM3 ROBO2 | 7.34e-04 | 583 | 207 | 15 | GO:0097060 |
| GeneOntologyCellularComponent | neuron to neuron synapse | GPHN NRG1 RPL30 ADGRB1 ADCY1 ADCY8 DST PURA SORCS2 CALB1 EGLN1 ALS2 P2RX3 ROBO2 | 7.52e-04 | 523 | 207 | 14 | GO:0098984 |
| GeneOntologyCellularComponent | neuron spine | 8.26e-04 | 247 | 207 | 9 | GO:0044309 | |
| GeneOntologyCellularComponent | sperm principal piece | 9.30e-04 | 44 | 207 | 4 | GO:0097228 | |
| GeneOntologyCellularComponent | endosome | SLC46A2 ABCA1 CFTR ANXA8L1 SRC ADCY5 ADCY6 JAK2 CBLIF SORCS2 RAB3A RAB3B RAC1 FLT1 RAB3D SLC26A9 ADAM30 MYO1B ALS2 ANXA8 RET AP4E1 IGF2R | 1.31e-03 | 1167 | 207 | 23 | GO:0005768 |
| GeneOntologyCellularComponent | coated vesicle membrane | 1.40e-03 | 215 | 207 | 8 | GO:0030662 | |
| GeneOntologyCellularComponent | postsynaptic specialization | GPHN NRG1 RPL30 SRC ADGRB1 ADCY1 ADCY8 DST PURA SORCS2 EGLN1 ALS2 ROBO2 | 1.58e-03 | 503 | 207 | 13 | GO:0099572 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.76e-03 | 223 | 207 | 8 | GO:0098862 | |
| GeneOntologyCellularComponent | postsynaptic density | GPHN NRG1 RPL30 ADGRB1 ADCY1 ADCY8 DST PURA SORCS2 EGLN1 ALS2 ROBO2 | 1.87e-03 | 451 | 207 | 12 | GO:0014069 |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.87e-03 | 25 | 207 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | dynein complex | 2.01e-03 | 54 | 207 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | dendrite | GPHN MYH10 CFTR SRC ADGRB1 TENM2 ADCY2 ADCY8 ADCY9 PURA SORCS2 RAC1 DIP2B CALB1 SYNE1 ALS2 RET P2RX3 | 2.27e-03 | 858 | 207 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | GPHN MYH10 CFTR SRC ADGRB1 TENM2 ADCY2 ADCY8 ADCY9 PURA SORCS2 RAC1 DIP2B CALB1 SYNE1 ALS2 RET P2RX3 | 2.33e-03 | 860 | 207 | 18 | GO:0097447 |
| GeneOntologyCellularComponent | apical part of cell | NRG1 ATP6V1B2 ABCC4 MYO1A CFTR ADCY8 CBLIF NOS3 DYNC2H1 PDZK1P1 ANO1 SLC26A9 MYO1B SLC6A8 | 2.40e-03 | 592 | 207 | 14 | GO:0045177 |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 2.57e-03 | 237 | 207 | 8 | GO:0030136 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | SLC46A2 ATP6V1B2 ABCC4 SLC6A17 CFTR ANXA8L1 ADCY8 SORCS2 GOLGA5 RAB3A RAB3B NOS3 RAC1 TPRG1L RAB3D SLC26A9 ADAM30 MYO1B ANXA8 RET CEMIP IGF2R NECAP2 SCARB1 | 2.61e-03 | 1307 | 207 | 24 | GO:0030659 |
| GeneOntologyCellularComponent | 9+2 motile cilium | 2.64e-03 | 238 | 207 | 8 | GO:0097729 | |
| GeneOntologyCellularComponent | motile cilium | FSIP1 ODAD4 FSIP2 AKAP4 DNAH8 DNAH10 DYNC2H1 IFT81 DNAI4 CATSPERB | 2.94e-03 | 355 | 207 | 10 | GO:0031514 |
| GeneOntologyCellularComponent | asymmetric synapse | GPHN NRG1 RPL30 ADGRB1 ADCY1 ADCY8 DST PURA SORCS2 EGLN1 ALS2 ROBO2 | 2.96e-03 | 477 | 207 | 12 | GO:0032279 |
| GeneOntologyCellularComponent | vesicle membrane | SLC46A2 ATP6V1B2 ABCC4 SLC6A17 CFTR ANXA8L1 ADCY8 SORCS2 GOLGA5 RAB3A RAB3B NOS3 RAC1 TPRG1L RAB3D SLC26A9 ADAM30 MYO1B ANXA8 RET CEMIP IGF2R NECAP2 SCARB1 | 3.11e-03 | 1325 | 207 | 24 | GO:0012506 |
| GeneOntologyCellularComponent | supramolecular fiber | MYH8 MYH10 EPPK1 MYO1A SRC POTEKP DCN AKAP4 DST MID1 RASSF3 DNAH8 RAC1 DNAH10 DYNC2H1 SYNE1 RAB3D MYO1B ARPC3 GSN RTL1 RASSF1 | 3.25e-03 | 1179 | 207 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | site of double-strand break | 3.33e-03 | 101 | 207 | 5 | GO:0035861 | |
| GeneOntologyCellularComponent | actin filament | 3.38e-03 | 146 | 207 | 6 | GO:0005884 | |
| GeneOntologyCellularComponent | plasma membrane raft | 3.49e-03 | 147 | 207 | 6 | GO:0044853 | |
| GeneOntologyCellularComponent | phagocytic cup | 3.51e-03 | 31 | 207 | 3 | GO:0001891 | |
| GeneOntologyCellularComponent | supramolecular polymer | MYH8 MYH10 EPPK1 MYO1A SRC POTEKP DCN AKAP4 DST MID1 RASSF3 DNAH8 RAC1 DNAH10 DYNC2H1 SYNE1 RAB3D MYO1B ARPC3 GSN RTL1 RASSF1 | 3.52e-03 | 1187 | 207 | 22 | GO:0099081 |
| GeneOntologyCellularComponent | nuclear chromosome | 3.91e-03 | 254 | 207 | 8 | GO:0000228 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 4.40e-03 | 67 | 207 | 4 | GO:0098686 | |
| GeneOntologyCellularComponent | ruffle | 4.54e-03 | 206 | 207 | 7 | GO:0001726 | |
| GeneOntologyCellularComponent | caveola | 4.98e-03 | 111 | 207 | 5 | GO:0005901 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 5.06e-03 | 11 | 207 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | MCM complex | 5.06e-03 | 11 | 207 | 2 | GO:0042555 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 5.06e-03 | 11 | 207 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 5.06e-03 | 11 | 207 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | hemidesmosome | 5.06e-03 | 11 | 207 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 5.06e-03 | 11 | 207 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | melanosome | 5.37e-03 | 113 | 207 | 5 | GO:0042470 | |
| GeneOntologyCellularComponent | pigment granule | 5.37e-03 | 113 | 207 | 5 | GO:0048770 | |
| Domain | Guanylate_cyc | 1.49e-13 | 19 | 203 | 9 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 1.49e-13 | 19 | 203 | 9 | PS50125 | |
| Domain | A/G_cyclase | 1.49e-13 | 19 | 203 | 9 | IPR001054 | |
| Domain | GUANYLATE_CYCLASE_1 | 1.49e-13 | 19 | 203 | 9 | PS00452 | |
| Domain | CYCc | 1.49e-13 | 19 | 203 | 9 | SM00044 | |
| Domain | A/G_cyclase_CS | 3.79e-12 | 17 | 203 | 8 | IPR018297 | |
| Domain | - | 6.76e-12 | 18 | 203 | 8 | 3.30.70.1230 | |
| Domain | Nucleotide_cyclase | 6.76e-12 | 18 | 203 | 8 | IPR029787 | |
| Domain | AC_N | 4.21e-11 | 8 | 203 | 6 | IPR032628 | |
| Domain | Adcy | 4.21e-11 | 8 | 203 | 6 | IPR030672 | |
| Domain | AC_N | 4.21e-11 | 8 | 203 | 6 | PF16214 | |
| Domain | P-loop_NTPase | NUGGC ATP6V1B2 ABCC4 MYH8 ABCA1 MYH10 ERCC3 MYO1A ERCC6L CFTR MCM4 ABCA8 NLRC4 RRAGC SHPRH HELZ RAB3A RAB3B DNAH8 RAC1 DNAH10 DYNC2H1 DHX37 RAB3D MYO1B RFC1 SLFN13 DDX53 SLFN11 POLQ YME1L1 SNRNP200 MYO16 | 1.71e-10 | 848 | 203 | 33 | IPR027417 |
| Domain | Adcy_conserved_dom | 8.59e-10 | 6 | 203 | 5 | IPR009398 | |
| Domain | DUF1053 | 8.59e-10 | 6 | 203 | 5 | PF06327 | |
| Domain | - | NUGGC ATP6V1B2 ABCC4 ABCA1 ERCC3 ERCC6L CFTR MCM4 ABCA8 NLRC4 RRAGC SHPRH HELZ RAB3A RAB3B DNAH8 RAC1 DNAH10 DYNC2H1 DHX37 RAB3D RFC1 SLFN13 DDX53 SLFN11 POLQ YME1L1 SNRNP200 | 1.06e-08 | 746 | 203 | 28 | 3.40.50.300 |
| Domain | AAA | ABCC4 ABCA1 CFTR MCM4 ABCA8 DNAH8 DNAH10 DYNC2H1 RFC1 YME1L1 SNRNP200 | 5.06e-07 | 144 | 203 | 11 | SM00382 |
| Domain | AAA+_ATPase | ABCC4 ABCA1 CFTR MCM4 ABCA8 DNAH8 DNAH10 DYNC2H1 RFC1 YME1L1 SNRNP200 | 5.06e-07 | 144 | 203 | 11 | IPR003593 |
| Domain | NA_NEUROTRAN_SYMP_2 | 3.68e-05 | 18 | 203 | 4 | PS00754 | |
| Domain | SNF | 4.62e-05 | 19 | 203 | 4 | PF00209 | |
| Domain | Na/ntran_symport | 4.62e-05 | 19 | 203 | 4 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 4.62e-05 | 19 | 203 | 4 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 4.62e-05 | 19 | 203 | 4 | PS50267 | |
| Domain | Myosin_head_motor_dom | 5.41e-05 | 38 | 203 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 5.41e-05 | 38 | 203 | 5 | PS51456 | |
| Domain | Myosin_head | 5.41e-05 | 38 | 203 | 5 | PF00063 | |
| Domain | MYSc | 5.41e-05 | 38 | 203 | 5 | SM00242 | |
| Domain | DHC_N1 | 6.81e-05 | 8 | 203 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 6.81e-05 | 8 | 203 | 3 | IPR013594 | |
| Domain | CFTR/ABCC7 | 1.18e-04 | 2 | 203 | 2 | IPR009147 | |
| Domain | AnnexinVIII | 1.18e-04 | 2 | 203 | 2 | IPR009115 | |
| Domain | Helicase_C | 1.68e-04 | 107 | 203 | 7 | PF00271 | |
| Domain | HELICc | 1.68e-04 | 107 | 203 | 7 | SM00490 | |
| Domain | Helicase_C | 1.78e-04 | 108 | 203 | 7 | IPR001650 | |
| Domain | HELICASE_CTER | 1.89e-04 | 109 | 203 | 7 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.89e-04 | 109 | 203 | 7 | PS51192 | |
| Domain | DEXDc | 1.89e-04 | 109 | 203 | 7 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.00e-04 | 110 | 203 | 7 | IPR014001 | |
| Domain | Rhs_assc_core | 3.50e-04 | 3 | 203 | 2 | IPR022385 | |
| Domain | DUF2075 | 3.50e-04 | 3 | 203 | 2 | PF09848 | |
| Domain | DUF2075 | 3.50e-04 | 3 | 203 | 2 | IPR018647 | |
| Domain | GPR137 | 3.50e-04 | 3 | 203 | 2 | IPR029723 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.22e-04 | 14 | 203 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 4.22e-04 | 14 | 203 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 4.22e-04 | 14 | 203 | 3 | IPR013602 | |
| Domain | DHC_N2 | 4.22e-04 | 14 | 203 | 3 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 4.22e-04 | 14 | 203 | 3 | IPR011704 | |
| Domain | MT | 4.22e-04 | 14 | 203 | 3 | PF12777 | |
| Domain | AAA_8 | 4.22e-04 | 14 | 203 | 3 | PF12780 | |
| Domain | AAA_5 | 4.22e-04 | 14 | 203 | 3 | PF07728 | |
| Domain | DHC_fam | 5.23e-04 | 15 | 203 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 5.23e-04 | 15 | 203 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 5.23e-04 | 15 | 203 | 3 | IPR004273 | |
| Domain | Tox-GHH_dom | 6.95e-04 | 4 | 203 | 2 | IPR028916 | |
| Domain | Tox-GHH | 6.95e-04 | 4 | 203 | 2 | PF15636 | |
| Domain | Ten_N | 6.95e-04 | 4 | 203 | 2 | IPR009471 | |
| Domain | Ten_N | 6.95e-04 | 4 | 203 | 2 | PF06484 | |
| Domain | HNOB | 6.95e-04 | 4 | 203 | 2 | PF07700 | |
| Domain | TENEURIN_N | 6.95e-04 | 4 | 203 | 2 | PS51361 | |
| Domain | CarboxyPept-like_regulatory | 7.69e-04 | 17 | 203 | 3 | IPR008969 | |
| Domain | YD | 1.15e-03 | 5 | 203 | 2 | IPR006530 | |
| Domain | Na/ntran_symport_orphan | 1.15e-03 | 5 | 203 | 2 | IPR002438 | |
| Domain | DUF4704 | 1.15e-03 | 5 | 203 | 2 | IPR031570 | |
| Domain | DUF4704 | 1.15e-03 | 5 | 203 | 2 | PF15787 | |
| Domain | RCC1 | 1.26e-03 | 20 | 203 | 3 | PF00415 | |
| Domain | RCC1_1 | 1.46e-03 | 21 | 203 | 3 | PS00625 | |
| Domain | RCC1_2 | 1.46e-03 | 21 | 203 | 3 | PS00626 | |
| Domain | RCC1_3 | 1.46e-03 | 21 | 203 | 3 | PS50012 | |
| Domain | - | 1.67e-03 | 22 | 203 | 3 | 2.130.10.30 | |
| Domain | Reg_chr_condens | 1.67e-03 | 22 | 203 | 3 | IPR000408 | |
| Domain | - | 1.71e-03 | 6 | 203 | 2 | 3.90.1290.10 | |
| Domain | HNOB_dom_associated | 1.71e-03 | 6 | 203 | 2 | IPR011645 | |
| Domain | PH_BEACH | 1.71e-03 | 6 | 203 | 2 | PF14844 | |
| Domain | C-RASSF | 1.71e-03 | 6 | 203 | 2 | IPR033614 | |
| Domain | Nore1-SARAH | 1.71e-03 | 6 | 203 | 2 | PF16517 | |
| Domain | HNOBA | 1.71e-03 | 6 | 203 | 2 | PF07701 | |
| Domain | ABC_tran | 1.81e-03 | 48 | 203 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.81e-03 | 48 | 203 | 4 | PS50893 | |
| Domain | IQ | 1.90e-03 | 81 | 203 | 5 | SM00015 | |
| Domain | RCC1/BLIP-II | 1.91e-03 | 23 | 203 | 3 | IPR009091 | |
| Domain | ABC_TRANSPORTER_1 | 1.96e-03 | 49 | 203 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 2.11e-03 | 50 | 203 | 4 | IPR003439 | |
| Domain | DAGAT | 2.38e-03 | 7 | 203 | 2 | PF03982 | |
| Domain | DAGAT | 2.38e-03 | 7 | 203 | 2 | IPR007130 | |
| Domain | Plectin | 2.38e-03 | 7 | 203 | 2 | PF00681 | |
| Domain | AlbA_2 | 2.38e-03 | 7 | 203 | 2 | PF04326 | |
| Domain | Schlafen | 2.38e-03 | 7 | 203 | 2 | IPR029684 | |
| Domain | Schlafen_AAA_dom | 2.38e-03 | 7 | 203 | 2 | IPR007421 | |
| Domain | Plectin_repeat | 2.38e-03 | 7 | 203 | 2 | IPR001101 | |
| Domain | Myosin_TH1 | 2.38e-03 | 7 | 203 | 2 | PF06017 | |
| Domain | Myosin_TH1 | 2.38e-03 | 7 | 203 | 2 | IPR010926 | |
| Domain | TH1 | 2.38e-03 | 7 | 203 | 2 | PS51757 | |
| Domain | PLEC | 2.38e-03 | 7 | 203 | 2 | SM00250 | |
| Domain | IQ_motif_EF-hand-BS | 3.01e-03 | 90 | 203 | 5 | IPR000048 | |
| Domain | Villin/Gelsolin | 3.15e-03 | 8 | 203 | 2 | IPR007122 | |
| Domain | PH-BEACH_dom | 3.15e-03 | 8 | 203 | 2 | IPR023362 | |
| Domain | - | 3.15e-03 | 8 | 203 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 3.15e-03 | 8 | 203 | 2 | PS51783 | |
| Domain | GEL | 3.15e-03 | 8 | 203 | 2 | SM00262 | |
| Domain | IQ | 3.46e-03 | 93 | 203 | 5 | PS50096 | |
| Domain | Heme_NO-bd | 4.02e-03 | 9 | 203 | 2 | IPR011644 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 2.27e-12 | 10 | 158 | 7 | M19522 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | 2.27e-12 | 10 | 158 | 7 | MM14668 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY | 2.49e-12 | 16 | 158 | 8 | M47645 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY | 2.49e-12 | 16 | 158 | 8 | M47650 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 6.25e-11 | 14 | 158 | 7 | MM14669 | |
| Pathway | REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY | 6.25e-11 | 14 | 158 | 7 | M750 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 6.77e-11 | 46 | 158 | 10 | M39828 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | SRC ADCY1 ADCY2 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 JAK2 AKT1 RAC1 | 9.21e-11 | 63 | 158 | 11 | M8 |
| Pathway | KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY | 1.16e-10 | 15 | 158 | 7 | M47794 | |
| Pathway | PID_LPA4_PATHWAY | 1.16e-10 | 15 | 158 | 7 | M56 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY | 1.16e-10 | 15 | 158 | 7 | M47504 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.04e-10 | 16 | 158 | 7 | MM14492 | |
| Pathway | WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE | 2.04e-10 | 16 | 158 | 7 | M39849 | |
| Pathway | REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING | 3.44e-10 | 17 | 158 | 7 | M26995 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY | 3.44e-10 | 17 | 158 | 7 | M47544 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.33e-09 | 20 | 158 | 7 | M759 | |
| Pathway | PID_LYSOPHOSPHOLIPID_PATHWAY | 2.48e-09 | 65 | 158 | 10 | M15 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 5.73e-09 | 24 | 158 | 7 | M47520 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 9.09e-09 | 55 | 158 | 9 | M39763 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.07e-08 | 26 | 158 | 7 | MM14495 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 1.07e-08 | 26 | 158 | 7 | M47553 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.43e-08 | 27 | 158 | 7 | M47518 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 1.43e-08 | 27 | 158 | 7 | M47519 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 1.89e-08 | 28 | 158 | 7 | M47647 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 2.47e-08 | 29 | 158 | 7 | M47627 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 2.47e-08 | 29 | 158 | 7 | M47515 | |
| Pathway | REACTOME_GPER1_SIGNALING | 3.16e-08 | 45 | 158 | 8 | M45008 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 4.08e-08 | 31 | 158 | 7 | M47507 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY | 5.17e-08 | 32 | 158 | 7 | M47506 | |
| Pathway | REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION | 6.50e-08 | 33 | 158 | 7 | M11575 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 6.50e-08 | 33 | 158 | 7 | MM15058 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 1.00e-07 | 35 | 158 | 7 | M47969 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 1.51e-07 | 37 | 158 | 7 | M749 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 2.21e-07 | 39 | 158 | 7 | MM14496 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 3.18e-07 | 41 | 158 | 7 | M512 | |
| Pathway | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION | 4.42e-07 | 85 | 158 | 9 | M3578 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 4.47e-07 | 43 | 158 | 7 | M933 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 4.47e-07 | 43 | 158 | 7 | M954 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 4.47e-07 | 43 | 158 | 7 | M29837 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 5.26e-07 | 44 | 158 | 7 | MM15709 | |
| Pathway | KEGG_GAP_JUNCTION | 7.23e-07 | 90 | 158 | 9 | M4013 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 9.74e-07 | 48 | 158 | 7 | M10775 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 1.70e-06 | 52 | 158 | 7 | M920 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 1.92e-06 | 101 | 158 | 9 | M1979 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 2.21e-06 | 54 | 158 | 7 | M26911 | |
| Pathway | WP_CHEMOKINE_SIGNALING | ADCY1 ADCY2 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 JAK2 AKT1 VAV3 RAC1 | 2.47e-06 | 165 | 158 | 11 | M39400 |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 4.56e-06 | 60 | 158 | 7 | MM15708 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 4.56e-06 | 60 | 158 | 7 | M976 | |
| Pathway | WP_CHEMOKINE_SIGNALING_PATHWAY | ADCY1 ADCY2 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 JAK2 AKT1 VAV3 RAC1 | 7.07e-06 | 184 | 158 | 11 | MM15943 |
| Pathway | WP_G_PROTEIN_SIGNALING_PATHWAYS | 7.42e-06 | 90 | 158 | 8 | MM15882 | |
| Pathway | WP_G_PROTEIN_SIGNALING | 8.06e-06 | 91 | 158 | 8 | M39426 | |
| Pathway | KEGG_CHEMOKINE_SIGNALING_PATHWAY | ADCY1 ADCY2 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 JAK2 AKT1 VAV3 RAC1 | 8.68e-06 | 188 | 158 | 11 | M4844 |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 1.11e-05 | 95 | 158 | 8 | M29842 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 1.42e-05 | 71 | 158 | 7 | MM14491 | |
| Pathway | PID_S1P_S1P3_PATHWAY | 1.59e-05 | 29 | 158 | 5 | M55 | |
| Pathway | BIOCARTA_RACC_PATHWAY | 1.88e-05 | 15 | 158 | 4 | M22002 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | NRG1 RPS6KA2 SRC ADCY1 ADCY2 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 RAC1 | 1.96e-05 | 205 | 158 | 11 | M752 |
| Pathway | WP_PURINE_METABOLISM | ADCY1 ADCY2 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 POLD1 GUCY1B2 GUCY1B1 | 2.26e-05 | 171 | 158 | 10 | MM15909 |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 2.32e-05 | 105 | 158 | 8 | MM15206 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | NRG1 SRC ADCY1 ADCY2 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 RRAGC AKT1 RAC1 | 2.69e-05 | 252 | 158 | 12 | MM15585 |
| Pathway | WP_THERMOGENESIS | 2.84e-05 | 108 | 158 | 8 | M39746 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | SRC ADCY1 ADCY2 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 VAV3 RAC1 ARPC3 | 3.61e-05 | 219 | 158 | 11 | M29836 |
| Pathway | KEGG_OOCYTE_MEIOSIS | 3.94e-05 | 113 | 158 | 8 | M16817 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 3.94e-05 | 113 | 158 | 8 | M27471 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 4.47e-05 | 115 | 158 | 8 | M9387 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | NRG1 RPS6KA2 SRC ADCY1 ADCY2 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 RAB3A RAC1 | 5.26e-05 | 270 | 158 | 12 | M15514 |
| Pathway | WP_CANCER_PATHWAYS | HSP90B1 ADCY1 ADCY2 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 JAK2 AKT1 RAC1 RALGDS EGLN1 RET IFNAR2 RASSF1 IL7 | 5.46e-05 | 507 | 158 | 17 | M48302 |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 6.67e-05 | 90 | 158 | 7 | M835 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 6.67e-05 | 90 | 158 | 7 | M6467 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 6.84e-05 | 157 | 158 | 9 | M4904 | |
| Pathway | KEGG_PURINE_METABOLISM | 7.54e-05 | 159 | 158 | 9 | M14314 | |
| Pathway | WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING | 9.40e-05 | 66 | 158 | 6 | M39684 | |
| Pathway | WP_SILDENAFIL_TREATMENT | 1.14e-04 | 23 | 158 | 4 | M46455 | |
| Pathway | PID_ERBB2_ERBB3_PATHWAY | 1.27e-04 | 44 | 158 | 5 | M175 | |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | 1.32e-04 | 134 | 158 | 8 | M29840 | |
| Pathway | WP_ANGIOGENESIS | 1.36e-04 | 24 | 158 | 4 | M39556 | |
| Pathway | KEGG_MELANOGENESIS | 1.39e-04 | 101 | 158 | 7 | M7761 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 1.54e-04 | 137 | 158 | 8 | MM15182 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 2.10e-04 | 108 | 158 | 7 | M17034 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | NRG1 SRC ADCY1 ADCY2 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 RRAGC AKT1 RAC1 | 2.12e-04 | 313 | 158 | 12 | M27867 |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 2.16e-04 | 144 | 158 | 8 | MM14501 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 2.18e-04 | 27 | 158 | 4 | M27422 | |
| Pathway | PID_GLYPICAN_1PATHWAY | 2.18e-04 | 27 | 158 | 4 | M33 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 2.86e-04 | 150 | 158 | 8 | M27440 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 3.32e-04 | 30 | 158 | 4 | MM15170 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 3.41e-04 | 154 | 158 | 8 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 3.72e-04 | 156 | 158 | 8 | M39475 | |
| Pathway | WP_EGFEGFR_SIGNALING | 4.79e-04 | 162 | 158 | 8 | M39334 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP6V1B2 ABCC4 ABCA1 CFTR ADCY1 ADCY2 ADCY5 ABCA8 ADCY6 ADCY7 ADCY8 ADCY9 MICU1 SLC25A18 ANO1 SLC26A9 SLC6A15 SCARB1 YME1L1 | 5.85e-04 | 736 | 158 | 19 | M27287 |
| Pathway | PID_AR_PATHWAY | 5.96e-04 | 61 | 158 | 5 | M58 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 6.23e-04 | 211 | 158 | 9 | MM14502 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 6.51e-04 | 94 | 158 | 6 | M2843 | |
| Pathway | WP_AGERAGE_PATHWAY | 8.55e-04 | 66 | 158 | 5 | M39420 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 1.05e-03 | 103 | 158 | 6 | MM14752 | |
| Pathway | REACTOME_DUAL_INCISION_IN_GG_NER | 1.11e-03 | 41 | 158 | 4 | M27595 | |
| Pathway | PID_ERBB1_DOWNSTREAM_PATHWAY | 1.16e-03 | 105 | 158 | 6 | M164 | |
| Pathway | PID_EPHA2_FWD_PATHWAY | 1.17e-03 | 19 | 158 | 3 | M273 | |
| Pathway | REACTOME_DUAL_INCISION_IN_GG_NER | 1.22e-03 | 42 | 158 | 4 | MM15306 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 1.22e-03 | 106 | 158 | 6 | M27077 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.34e-03 | 147 | 158 | 7 | MM15854 | |
| Pubmed | Role of the calcium modulated cyclases in the development of the retinal projections. | 8.81e-15 | 9 | 208 | 7 | 17229090 | |
| Pubmed | 8.81e-15 | 9 | 208 | 7 | 12503609 | ||
| Pubmed | Purification and characterization of a soluble form of mammalian adenylyl cyclase. | 2.92e-14 | 10 | 208 | 7 | 8663304 | |
| Pubmed | 2.92e-14 | 10 | 208 | 7 | 16615126 | ||
| Pubmed | Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. | 2.92e-14 | 10 | 208 | 7 | 11884542 | |
| Pubmed | 8.00e-14 | 11 | 208 | 7 | 10089566 | ||
| Pubmed | 8.00e-14 | 11 | 208 | 7 | 10808179 | ||
| Pubmed | 1.91e-13 | 12 | 208 | 7 | 10807185 | ||
| Pubmed | Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. | 8.19e-13 | 14 | 208 | 7 | 14993377 | |
| Pubmed | 2.70e-12 | 16 | 208 | 7 | 17567809 | ||
| Pubmed | Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. | 3.52e-12 | 9 | 208 | 6 | 9417641 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GPHN RPL30 HSP90B1 MYH10 ERCC6L MCM4 GPATCH4 DDB1 NEK9 MPRIP CSDE1 DST AHCY HELZ GOLGA5 TASOR KNL1 EGLN1 DPYSL4 MYO1B HEATR1 RFC1 PA2G4 SAP30BP SLFN11 LRBA SNRNP200 | 1.61e-11 | 934 | 208 | 27 | 33916271 |
| Pubmed | 1.92e-11 | 11 | 208 | 6 | 11299302 | ||
| Pubmed | 1.52e-10 | 7 | 208 | 5 | 12613887 | ||
| Pubmed | cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. | 2.04e-10 | 15 | 208 | 6 | 2165385 | |
| Pubmed | Ascorbic acid is a regulator of the intracellular cAMP concentration: old molecule, new functions? | 1.24e-09 | 4 | 208 | 4 | 18835269 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYH10 EPPK1 ERCC6L RO60 ODAD4 NEK9 MPRIP PURA AHCY UQCRC2 HERC1 RAC1 MMS22L DHX37 POLD1 PARP3 MYO1B ALS2 HEATR1 ARPC3 GSN LOXHD1 PA2G4 MRPS5 LRBA POLQ EIF2AK2 SNRNP200 | 3.83e-09 | 1284 | 208 | 28 | 17353931 |
| Pubmed | Expression of adenylyl cyclase mRNAs in the denervated and in the developing mouse skeletal muscle. | 5.58e-09 | 12 | 208 | 5 | 9611134 | |
| Pubmed | Mapping of adenylyl cyclase genes type I, II, III, IV, V, and VI in mouse. | 1.85e-08 | 6 | 208 | 4 | 7766992 | |
| Pubmed | Expression and regulation of adenylyl cyclase isoforms in the human adrenal gland. | 1.85e-08 | 6 | 208 | 4 | 11549699 | |
| Pubmed | 2.09e-08 | 15 | 208 | 5 | 7937899 | ||
| Pubmed | 2.77e-08 | 31 | 208 | 6 | 12626323 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL30 HSP90B1 MYH10 MCM4 GPATCH4 RO60 DDB1 NEK9 AHCY UQCRC2 RAC1 SLC25A24 DNAH10 DYNC2H1 DHX37 POLD1 SYNE1 MYO1B HEATR1 AGPS RFC1 PBRM1 IGF2R GUCY1B2 PA2G4 PDCD11 EIF2AK2 SNRNP200 | 3.53e-08 | 1425 | 208 | 28 | 30948266 |
| Pubmed | SRC GPATCH4 ADCY9 CLCC1 DST BBX DCLRE1A GOLGA5 TASOR EGLN1 SLC6A15 AGPS AP4E1 IGF2R NECAP2 TENM3 SLFN13 GCC2 LRBA SNRNP200 | 5.44e-08 | 777 | 208 | 20 | 35844135 | |
| Pubmed | RPL30 HSP90B1 RO60 COG3 ADCY6 ADCY9 CLCC1 UQCRC2 GOLGA5 RAB3A RAC1 SUN1 RAB3D SLC6A15 AGPS AP4E1 SLC6A8 IGF2R PA2G4 SCARB1 MRPS5 LRBA | 7.52e-08 | 952 | 208 | 22 | 38569033 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | HSP90B1 MYH8 MYH10 EPPK1 MYO1A CFTR MCM4 MPRIP AHCY UQCRC2 RAB3B SLC25A24 SPTLC2 MYO1B GSN SERPINC1 LRBA YME1L1 | 8.27e-08 | 647 | 208 | 18 | 26618866 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ABCC4 MYH10 RPS6KA2 SRC SRF COG3 NEK9 ADCY1 SLC25A37 CLCC1 MICU1 SBK1 CSDE1 JAK2 PURA ANKAR SHPRH RASSF3 XYLB PMS2P2 DIP2B SOBP GPR137C GCC2 SCARB1 USP40 GPR137B LRBA | 8.78e-08 | 1489 | 208 | 28 | 28611215 |
| Pubmed | ATP6V1B2 ERCC3 GPATCH4 MPRIP MICU1 CSDE1 PWWP2A DST BBX PURA HELZ UQCRC2 TASOR RAC1 SLC25A24 POLD1 SYNE1 HEATR1 ARPC3 PBRM1 TIAL1 PA2G4 SAP30BP PDCD11 MRPS5 EIF2AK2 YME1L1 EDRF1 | 9.80e-08 | 1497 | 208 | 28 | 31527615 | |
| Pubmed | HSP90B1 MYH10 EPPK1 RO60 CLCC1 CSDE1 AHCY SYNE1 AGPS PA2G4 PDCD11 SLFN11 EIF2AK2 YME1L1 SNRNP200 | 1.51e-07 | 463 | 208 | 15 | 34901782 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL30 HSP90B1 MYH10 ERCC3 MCM4 GPATCH4 DDB1 NEK9 MPRIP CSDE1 DST AHCY UQCRC2 SPTLC2 DHX37 POLD1 MYO1B HEATR1 AGPS RFC1 PA2G4 PDCD11 WDFY3 EIF2AK2 YME1L1 SNRNP200 | 1.75e-07 | 1353 | 208 | 26 | 29467282 |
| Pubmed | 2.11e-07 | 3 | 208 | 3 | 18448650 | ||
| Pubmed | 2.11e-07 | 3 | 208 | 3 | 26493996 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ATP6V1B2 HSP90B1 EPPK1 SRC MCM4 DDB1 DST AHCY UQCRC2 SYNE1 SUN1 MYO1B HEATR1 AGPS ARPC3 GSN PBRM1 IGF2R TIAL1 PA2G4 PDCD11 SNRNP200 | 2.61e-07 | 1024 | 208 | 22 | 24711643 |
| Pubmed | RPL30 ATP6V1B2 HSP90B1 EARS2 DDB1 ADCY9 CLCC1 MPRIP MICU1 MLLT11 UQCRC2 GOLGA5 DYNC2H1 POLD1 SYNE1 IFT81 SUN1 SLC6A15 HEATR1 SLC6A8 IGF2R PA2G4 PDCD11 MRPS5 YME1L1 SNRNP200 EDRF1 | 3.04e-07 | 1487 | 208 | 27 | 33957083 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | RPL30 HSP90B1 MYH10 ERCC3 EPPK1 MCM4 GPATCH4 DDB1 MPRIP CSDE1 DST UQCRC2 SLC25A18 DHX37 SYNE1 MYO1B HEATR1 GSN PDCD11 EIF2AK2 SNRNP200 | 3.08e-07 | 949 | 208 | 21 | 36574265 |
| Pubmed | GPHN MYH10 RPS6KA2 SRC DDB1 TENM2 NEK9 MPRIP DST PURA RAB3A RAB3B RAC1 DIP2B SYNE1 DPYSL4 ARPC3 GSN PBRM1 IGF2R WDFY3 | 3.91e-07 | 963 | 208 | 21 | 28671696 | |
| Pubmed | RPL30 MYH10 EPPK1 MCM4 DDB1 CSDE1 DST HELZ UQCRC2 DHX37 MYO1B HEATR1 RFC1 PBRM1 IGF2R PDCD11 SNRNP200 | 4.84e-07 | 653 | 208 | 17 | 22586326 | |
| Pubmed | ERCC6L DDB1 ADCY9 CLCC1 MID1 HELZ DCLRE1A GOLGA5 TASOR KNL1 EGLN1 SUN1 SLC6A15 SLC6A8 IGF2R NECAP2 GUCY1B1 ARPIN | 5.13e-07 | 733 | 208 | 18 | 34672954 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPL30 HSP90B1 MYH10 ERCC3 EPPK1 DDB1 MPRIP MICU1 CSDE1 DST AHCY UQCRC2 SLC25A24 DHX37 MYO1B HEATR1 RFC1 ARPC3 GSN PA2G4 SAP30BP PDCD11 EIF2AK2 SNRNP200 | 6.06e-07 | 1257 | 208 | 24 | 36526897 |
| Pubmed | Rab3 superprimes synaptic vesicles for release: implications for short-term synaptic plasticity. | 8.40e-07 | 4 | 208 | 3 | 16436611 | |
| Pubmed | Rab3 proteins involved in vesicle biogenesis and priming in embryonic mouse chromaffin cells. | 8.40e-07 | 4 | 208 | 3 | 20716109 | |
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 12167638 | ||
| Pubmed | 8.40e-07 | 4 | 208 | 3 | 15269275 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPL30 ERCC3 GPATCH4 DDB1 NUFIP1 CSDE1 PURA TASOR DHX37 HEATR1 RFC1 PBRM1 PA2G4 PDCD11 OGDHL EIF2AK2 YME1L1 SNRNP200 | 8.45e-07 | 759 | 208 | 18 | 35915203 |
| Pubmed | EARS2 GPATCH4 DDB1 ABCA8 ADCY6 ADCY9 NUFIP1 TC2N HELZ XYLB KNL1 ACTR8 POLD1 CECR2 PBRM1 ARSB SUDS3 SAP30BP TTC39A SLFN11 WDFY3 YME1L1 | 1.09e-06 | 1116 | 208 | 22 | 31753913 | |
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 1.21e-06 | 90 | 208 | 7 | 35654790 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | ATP6V1B2 HSP90B1 MYH10 RPS6KA2 DGKA ADCY6 DST PURA AHCY UQCRC2 RAB3A RAB3B SLC25A18 CALB1 RAB3D GSN | 1.21e-06 | 621 | 208 | 16 | 22794259 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | EPPK1 MCM4 AHCY UQCRC2 DNAH8 DHX37 POLD1 HEATR1 AGPS ARPC3 TIAL1 PA2G4 PDCD11 LRBA EIF2AK2 YME1L1 SNRNP200 | 1.35e-06 | 704 | 208 | 17 | 29955894 |
| Pubmed | MYH10 EPPK1 GPATCH4 RO60 MPRIP DST PURA AHCY AKT1 SPTLC2 MYO1B IGF2R PA2G4 PDCD11 MRPS5 YME1L1 | 1.59e-06 | 634 | 208 | 16 | 34591612 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPL30 HSP90B1 MYH10 EPPK1 MCM4 DDB1 NEK9 DST MID1 AHCY MLLT11 RAC1 POLD1 MYO1B RFC1 ARPC3 GSN PA2G4 MRPS5 SLFN11 EIF2AK2 SNRNP200 | 1.76e-06 | 1149 | 208 | 22 | 35446349 |
| Pubmed | Genetic susceptibility to distinct bladder cancer subphenotypes. | ABCC4 ABCA1 ERCC3 CGA AKT1 NOS3 RAC1 POLD1 PARP3 RET IFNAR2 IGF2R SCARB1 | 1.77e-06 | 421 | 208 | 13 | 19692168 |
| Pubmed | RPL30 HSP90B1 MYH8 MYH10 MYO1A DGKA ADCY6 DST BBX UQCRC2 TASOR RAB3A RAB3B DNAH8 RAC1 SLC25A18 SYNE1 IFT81 RAB3D MYO1B HEATR1 TIAL1 SAP30BP OGDHL POLQ | 1.98e-06 | 1442 | 208 | 25 | 35575683 | |
| Pubmed | Tctex-1, a novel interaction partner of Rab3D, is required for osteoclastic bone resorption. | 2.09e-06 | 5 | 208 | 3 | 21262767 | |
| Pubmed | A-kinase anchoring protein 4 binding proteins in the fibrous sheath of the sperm flagellum. | 2.09e-06 | 5 | 208 | 3 | 12606363 | |
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 11598194 | ||
| Pubmed | Mammalian adenylyl cyclase family members are randomly located on different chromosomes. | 2.09e-06 | 5 | 208 | 3 | 7959689 | |
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 15579468 | ||
| Pubmed | 2.09e-06 | 5 | 208 | 3 | 21228062 | ||
| Pubmed | Noc2 is essential in normal regulation of exocytosis in endocrine and exocrine cells. | 2.09e-06 | 5 | 208 | 3 | 15159548 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH8 ERCC3 RPS6KA2 SRC NEK9 MPRIP JAK2 DST PURA AHCY AKT1 RASSF3 VAV3 KNL1 MYO1B RET RTL1 RASSF1 SAP30BP | 2.70e-06 | 910 | 208 | 19 | 36736316 |
| Pubmed | PTEN identified as important risk factor of chronic obstructive pulmonary disease. | ABCC4 ABCA1 ERCC3 CGA AKT1 NOS3 RAC1 POLD1 RET IFNAR2 IGF2R SCARB1 | 3.01e-06 | 374 | 208 | 12 | 19625176 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | GPHN ATP6V1B2 ERCC3 CNPY4 DDB1 NEK9 CLCC1 SPTLC2 DHX37 SLC6A15 HEATR1 AGPS GSN IGF2R GCC2 SCARB1 MRPS5 | 3.38e-06 | 754 | 208 | 17 | 33060197 |
| Pubmed | ABCC4 ABCA1 ERCC3 CGA AKT1 NOS3 RAC1 POLD1 RET IFNAR2 IGF2R SCARB1 | 3.64e-06 | 381 | 208 | 12 | 18676680 | |
| Pubmed | Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China. | ABCC4 ABCA1 ERCC3 CGA AKT1 NOS3 RAC1 POLD1 RET IFNAR2 IGF2R SCARB1 | 3.74e-06 | 382 | 208 | 12 | 19170196 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | RPL30 HSP90B1 MYH10 EARS2 GPATCH4 DDB1 ADCY9 CLCC1 MICU1 DST UQCRC2 HERC1 GOLGA5 RAB3B SLC25A24 DIP2B SYNE1 EGLN1 SUN1 HEATR1 PDCD11 MRPS5 OGDHL EIF2AK2 YME1L1 | 3.78e-06 | 1496 | 208 | 25 | 32877691 |
| Pubmed | RPL30 HSP90B1 MYH10 GPATCH4 MPRIP PURA TASOR DHX37 MYO1B HEATR1 RFC1 ARPC3 GSN PBRM1 TIAL1 PDCD11 MRPS5 SNRNP200 | 3.93e-06 | 847 | 208 | 18 | 35850772 | |
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | ATP6V1B2 ERCC3 SRF RO60 CSDE1 DST DHX37 ALS2 HEATR1 AGPS ARPC3 AP4E1 SNRNP200 | 4.03e-06 | 454 | 208 | 13 | 33226137 |
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 19345227 | ||
| Pubmed | The RAB3-RIM Pathway Is Essential for the Release of Neuromodulators. | 4.16e-06 | 6 | 208 | 3 | 31679900 | |
| Pubmed | 4.16e-06 | 6 | 208 | 3 | 12192047 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RPL30 HSP90B1 MYH10 MCM4 GPATCH4 RO60 CSDE1 HELZ UQCRC2 DHX37 POLD1 HEATR1 AGPS RFC1 PBRM1 NECAP2 PA2G4 SAP30BP PDCD11 MRPS5 LRBA EIF2AK2 SNRNP200 | 4.72e-06 | 1318 | 208 | 23 | 30463901 |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 5.80e-06 | 212 | 208 | 9 | 33853758 | |
| Pubmed | ATP6V1B2 HSP90B1 MYH10 PURA AHCY UQCRC2 RAB3A RAC1 RBP3 DPYSL4 MYO1B GSN TIAL1 PA2G4 | 6.85e-06 | 552 | 208 | 14 | 36293380 | |
| Pubmed | RPL30 MYH10 GPATCH4 RO60 DDB1 MPRIP CSDE1 BBX PURA RFC1 GSN TIAL1 SAP30BP MRPS5 EIF2AK2 SNRNP200 | 7.02e-06 | 713 | 208 | 16 | 29802200 | |
| Pubmed | Mono-ubiquitination of Rabphilin 3A by UBE3A serves a non-degradative function. | 7.25e-06 | 7 | 208 | 3 | 33542309 | |
| Pubmed | 7.25e-06 | 7 | 208 | 3 | 9434938 | ||
| Pubmed | Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector. | 7.25e-06 | 7 | 208 | 3 | 35871249 | |
| Pubmed | 7.25e-06 | 7 | 208 | 3 | 10625539 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | HSP90B1 MYH10 MCM4 DDB1 RRAGC VAV3 DIP2B ARPC3 ARSB PA2G4 SNRNP200 | 8.08e-06 | 344 | 208 | 11 | 30333137 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | HSP90B1 MYH10 EPPK1 COG3 DDB1 DST AHCY RAB3A SLC25A24 DYNC2H1 SYNE1 MYO1B ARPC3 GSN LRBA SNRNP200 MYO16 | 8.24e-06 | 807 | 208 | 17 | 30575818 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | NRG1 ERCC6L CFTR SRC ADCY6 ADCY9 AKT1 GOLGA5 DIP2B SLC6A15 SLC6A8 IGF2R SCARB1 LRBA | 9.63e-06 | 569 | 208 | 14 | 30639242 |
| Pubmed | SRC ADCY9 MPRIP DST MID1 GOLGA5 SLC6A15 SLC6A8 IGF2R TENM3 ROBO2 LRBA | 9.96e-06 | 421 | 208 | 12 | 36976175 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | NRG1 NUGGC DDB1 SHPRH HERC1 FLT1 DHX37 POLD1 IFT81 LOXHD1 TIAL1 SAP30BP LRBA | 1.06e-05 | 497 | 208 | 13 | 36774506 |
| Pubmed | ATP6V1B2 MYH10 ERCC3 DDB1 RRAGC MPRIP DST HEATR1 ARPC3 GSN TIAL1 PA2G4 SERPINC1 EIF2AK2 SNRNP200 | 1.18e-05 | 660 | 208 | 15 | 32780723 | |
| Pubmed | GPHN ABCC4 COG3 CLCC1 RRAGC DST GOLGA5 SUN1 SLC6A15 IGF2R SCARB1 LRBA YME1L1 | 1.23e-05 | 504 | 208 | 13 | 34432599 | |
| Pubmed | GPHN MYH10 NEK9 MPRIP DST DPYSL4 MYO1B ARPC3 GSN PA2G4 SAP30BP ARPIN SNRNP200 | 1.28e-05 | 506 | 208 | 13 | 30890647 | |
| Pubmed | 1.28e-05 | 234 | 208 | 9 | 36243803 | ||
| Pubmed | HSP90B1 EPPK1 SLC6A17 MCM4 SHPRH GOLGA5 TASOR SLC25A24 DYNC2H1 DHX37 SYNE1 HEATR1 TIAL1 PA2G4 YME1L1 SNRNP200 | 1.40e-05 | 754 | 208 | 16 | 35906200 | |
| Pubmed | 1.40e-05 | 130 | 208 | 7 | 12421765 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | GPHN MCM4 NEK9 ADCY6 MPRIP MICU1 BBX HELZ UQCRC2 GOLGA5 RAC1 DYNC2H1 POLD1 IFT81 HEATR1 ARPC3 GSN PA2G4 GCC2 YME1L1 SNRNP200 EDRF1 | 1.58e-05 | 1321 | 208 | 22 | 27173435 |
| Pubmed | 1.72e-05 | 9 | 208 | 3 | 10455176 | ||
| Pubmed | Soluble guanylate cyclase generation of cGMP regulates migration of MGE neurons. | 1.72e-05 | 9 | 208 | 3 | 24155296 | |
| Pubmed | 1.72e-05 | 9 | 208 | 3 | 24666322 | ||
| Pubmed | 1.83e-05 | 187 | 208 | 8 | 26460568 | ||
| Pubmed | Apoptotic cells trigger a membrane-initiated pathway to increase ABCA1. | 2.45e-05 | 10 | 208 | 3 | 26075824 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.65e-05 | 197 | 208 | 8 | 20811636 | |
| Pubmed | HSP90B1 ERCC6L MCM4 DDB1 ADCY9 CLCC1 CSDE1 DST AHCY EGLN1 MYO1B IGF2R ARPIN LRBA SNRNP200 | 2.66e-05 | 708 | 208 | 15 | 39231216 | |
| Pubmed | RPL30 HSP90B1 ABCC4 ERCC6L DGKA MCM4 CLCC1 HELZ GOLGA5 DIP2B POLD1 HEATR1 AGPS ARPC3 IGF2R PA2G4 GCC2 LRBA EIF2AK2 YME1L1 | 2.66e-05 | 1168 | 208 | 20 | 19946888 | |
| Pubmed | RPL30 MYH10 ERCC3 RBMXL3 GPATCH4 DDB1 MPRIP CSDE1 PURA AHCY UQCRC2 RAC1 DHX37 MYO1B AGPS RFC1 PBRM1 TIAL1 PA2G4 SAP30BP PDCD11 EIF2AK2 | 2.78e-05 | 1371 | 208 | 22 | 36244648 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | HSP90B1 MYH10 EPPK1 MCM4 DDB1 PURA SHPRH ACTR8 RFC1 PBRM1 PDCD11 | 2.83e-05 | 394 | 208 | 11 | 27248496 |
| Interaction | NAA40 interactions | GPHN RPL30 HSP90B1 MYH10 ERCC6L MCM4 GPATCH4 DDB1 NEK9 MPRIP CSDE1 DST AHCY HELZ GOLGA5 TASOR KNL1 EGLN1 DPYSL4 MYO1B HEATR1 RFC1 PA2G4 SAP30BP SLFN11 LRBA SNRNP200 | 1.21e-06 | 978 | 198 | 27 | int:NAA40 |
| Interaction | RAB11A interactions | ATP6V1B2 MYH10 CFTR SRC ADCY9 CLCC1 DST TC2N PURA GOLGA5 RAB3B RAC1 CAPG SUN1 SLC6A15 GSN AP4E1 SLC6A8 IGF2R GCC2 SCARB1 PDCD11 WDFY3 LRBA | 2.27e-06 | 830 | 198 | 24 | int:RAB11A |
| Interaction | RAB3B interactions | ATP6V1B2 CFTR ADGRB1 CLCC1 NUFIP1 TC2N GOLGA5 RAB3A RAB3B RAB3D SLC6A15 SLC6A8 IGF2R SCARB1 | 2.50e-06 | 310 | 198 | 14 | int:RAB3B |
| Interaction | RIMS2 interactions | 5.89e-06 | 27 | 198 | 5 | int:RIMS2 | |
| Cytoband | 1p13.3 | 2.81e-04 | 69 | 208 | 4 | 1p13.3 | |
| Cytoband | 14q32.12 | 3.07e-04 | 29 | 208 | 3 | 14q32.12 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 2.28e-13 | 10 | 146 | 7 | 53 | |
| GeneFamily | Guanylate cyclases, soluble | 3.84e-04 | 4 | 146 | 2 | 820 | |
| GeneFamily | Schlafen family | 1.32e-03 | 7 | 146 | 2 | 1110 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.76e-03 | 8 | 146 | 2 | 939 | |
| GeneFamily | Diacylglycerol O-acyltransferase 2 family | 1.76e-03 | 8 | 146 | 2 | 1235 | |
| GeneFamily | Myosins, class I | 1.76e-03 | 8 | 146 | 2 | 1097 | |
| GeneFamily | Gelsolin/villins | 1.76e-03 | 8 | 146 | 2 | 950 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.98e-03 | 161 | 146 | 6 | 593 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 2.25e-03 | 9 | 146 | 2 | 1230 | |
| GeneFamily | Ras association domain family | 2.79e-03 | 10 | 146 | 2 | 1198 | |
| GeneFamily | Annexins|Endogenous ligands | 4.77e-03 | 13 | 146 | 2 | 404 | |
| GeneFamily | ATP binding cassette subfamily C | 4.77e-03 | 13 | 146 | 2 | 807 | |
| GeneFamily | Solute carriers | SLC46A2 SLC6A17 SLC25A37 SLC25A24 SLC25A18 SLC6A16 SLC26A9 SLC6A15 SLC6A8 | 4.84e-03 | 395 | 146 | 9 | 752 |
| GeneFamily | ATP binding cassette subfamily A | 5.53e-03 | 14 | 146 | 2 | 805 | |
| GeneFamily | Myosin heavy chains | 6.35e-03 | 15 | 146 | 2 | 1098 | |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP | FSIP1 RFTN2 ADCY6 ADCY9 SORCS2 HERC1 DIP2B TPRG1L IGF2R EDRF1 | 4.44e-06 | 200 | 206 | 10 | M387 |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_DN | 2.98e-05 | 199 | 206 | 9 | M3731 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_1H_BMDC_UP | 3.10e-05 | 200 | 206 | 9 | M3934 | |
| Coexpression | GSE7852_LN_VS_THYMUS_TREG_UP | 3.10e-05 | 200 | 206 | 9 | M5737 | |
| Coexpression | GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_UP | 3.10e-05 | 200 | 206 | 9 | M4379 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.12e-08 | 197 | 207 | 10 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-07 | 174 | 207 | 9 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.22e-07 | 185 | 207 | 9 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.32e-07 | 186 | 207 | 9 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.78e-07 | 190 | 207 | 9 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.90e-07 | 191 | 207 | 9 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.17e-07 | 193 | 207 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 3.93e-07 | 198 | 207 | 9 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.10e-07 | 199 | 207 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.10e-07 | 199 | 207 | 9 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-06 | 167 | 207 | 8 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-06 | 175 | 207 | 8 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.84e-06 | 177 | 207 | 8 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-06 | 179 | 207 | 8 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.45e-06 | 184 | 207 | 8 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.23e-06 | 191 | 207 | 8 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 3.36e-06 | 192 | 207 | 8 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 3.36e-06 | 192 | 207 | 8 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.36e-06 | 192 | 207 | 8 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | 368C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.49e-06 | 193 | 207 | 8 | 5f5904cec8b2967154ef2eab3c48f51df53aca4a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.49e-06 | 193 | 207 | 8 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 3.49e-06 | 193 | 207 | 8 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 3.49e-06 | 193 | 207 | 8 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.63e-06 | 194 | 207 | 8 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-06 | 195 | 207 | 8 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.77e-06 | 195 | 207 | 8 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-06 | 195 | 207 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.06e-06 | 197 | 207 | 8 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.06e-06 | 197 | 207 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 4.06e-06 | 197 | 207 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.22e-06 | 198 | 207 | 8 | 35499a5231818e3432cf69b5c4a58c02f7771db8 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.38e-06 | 199 | 207 | 8 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.54e-06 | 200 | 207 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.54e-06 | 200 | 207 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.54e-06 | 200 | 207 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 4.54e-06 | 200 | 207 | 8 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 4.54e-06 | 200 | 207 | 8 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.54e-06 | 200 | 207 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 4.54e-06 | 200 | 207 | 8 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.54e-06 | 200 | 207 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.65e-06 | 150 | 207 | 7 | 98fdc6bdfde84d680e11d8727502b79afbf64303 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.57e-06 | 153 | 207 | 7 | 9b6675ace8a83c8d446b722301d0ec4e6840f3fc | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 160 | 207 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 160 | 207 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-05 | 161 | 207 | 7 | 7af3b0d4fc7967f6b3e2d255d23fd8b1fd01a7af | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-05 | 161 | 207 | 7 | 98be0cf8228496b31f7f3e0efd8787e95eb626d1 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 167 | 207 | 7 | cf6206c506715cd846799c62cf7c06e3fa99f7af | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 169 | 207 | 7 | 30141f76e9bfc2b4586429857c72dbc85ba65cc9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-05 | 169 | 207 | 7 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 170 | 207 | 7 | 6210ee3bf29059e6149c047bb7e02c5f59441519 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.62e-05 | 172 | 207 | 7 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 1.68e-05 | 173 | 207 | 7 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.75e-05 | 174 | 207 | 7 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | mild_COVID-19-RBC|World / disease group, cell group and cell class (v2) | 1.80e-05 | 117 | 207 | 6 | 85210be67ddc31903764b7fa6d7029d9656753d3 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-05 | 176 | 207 | 7 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-05 | 177 | 207 | 7 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-05 | 177 | 207 | 7 | e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-05 | 177 | 207 | 7 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 177 | 207 | 7 | 73ba0f0b4b33f10e9f036d6d9befa48a1258e682 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-05 | 177 | 207 | 7 | 43ba6f12c2fb32698a420bf799d46ac1b558f146 | |
| ToppCell | mild_COVID-19-RBC|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.08e-05 | 120 | 207 | 6 | cccea760901558ec18d5cbb71c7971c5a51da571 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-05 | 179 | 207 | 7 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 2.10e-05 | 179 | 207 | 7 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.10e-05 | 179 | 207 | 7 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-05 | 180 | 207 | 7 | a407376209d80177bf7fc4200219030c83cb5f14 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.33e-05 | 182 | 207 | 7 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.33e-05 | 182 | 207 | 7 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-05 | 183 | 207 | 7 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-05 | 184 | 207 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-05 | 184 | 207 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-05 | 184 | 207 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.50e-05 | 184 | 207 | 7 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.68e-05 | 186 | 207 | 7 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | Control-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 2.77e-05 | 187 | 207 | 7 | 3a032432f780525f4f4c2a358897d9989b1ecae7 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.77e-05 | 187 | 207 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-05 | 189 | 207 | 7 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 2.97e-05 | 189 | 207 | 7 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-05 | 189 | 207 | 7 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 3.07e-05 | 190 | 207 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | facs-Skin-Anagen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 190 | 207 | 7 | 3466cebab16964e94da130d0673fa32e7d90b5ed | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 190 | 207 | 7 | 888ded899f0513d41bf655896d59ae8ef74e0978 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.07e-05 | 190 | 207 | 7 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.18e-05 | 191 | 207 | 7 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.18e-05 | 191 | 207 | 7 | d4f77c73311d1149466bbfe4adbd6a301946ec90 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.18e-05 | 191 | 207 | 7 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.18e-05 | 191 | 207 | 7 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.18e-05 | 191 | 207 | 7 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.18e-05 | 191 | 207 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.18e-05 | 191 | 207 | 7 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 3.18e-05 | 191 | 207 | 7 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 3.18e-05 | 191 | 207 | 7 | a98915bad9a4a61dd4cbca798914849b805f4a19 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.18e-05 | 191 | 207 | 7 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 192 | 207 | 7 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.28e-05 | 192 | 207 | 7 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.28e-05 | 192 | 207 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-05 | 193 | 207 | 7 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.39e-05 | 193 | 207 | 7 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.39e-05 | 193 | 207 | 7 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.39e-05 | 193 | 207 | 7 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.39e-05 | 193 | 207 | 7 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| Drug | 2',5'-dd3'-FSBA | 5.63e-13 | 10 | 208 | 7 | CID003081206 | |
| Drug | NC-5Z | 5.63e-13 | 10 | 208 | 7 | CID003035914 | |
| Drug | AC1L40QM | 1.54e-12 | 11 | 208 | 7 | CID000099213 | |
| Drug | B-Mlvp | 1.54e-12 | 11 | 208 | 7 | CID000195648 | |
| Drug | AC1NY9KD | 1.54e-12 | 11 | 208 | 7 | CID005771741 | |
| Drug | FCE 23884 | 7.86e-12 | 13 | 208 | 7 | CID000065898 | |
| Drug | AC1L1EV8 | 1.49e-11 | 8 | 208 | 6 | CID000002964 | |
| Drug | BMY 42393 | 2.90e-11 | 15 | 208 | 7 | CID000131961 | |
| Drug | 14,15-dihydroforskolin | 4.44e-11 | 9 | 208 | 6 | CID000194193 | |
| Drug | AC1L9HHR | ABCA1 MYO1A CFTR DGKA H1-9P ADCY1 ADCY2 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 AKT1 CALB1 PARP3 MYO1B GSN SCARB1 SERPINC1 LRBA | 1.03e-10 | 354 | 208 | 20 | CID000445141 |
| Drug | Nocloprostum | 1.13e-10 | 28 | 208 | 8 | CID006435380 | |
| Drug | AC1N2DGT | 2.09e-10 | 30 | 208 | 8 | CID004045015 | |
| Drug | Ro 41-9067 | 2.20e-10 | 19 | 208 | 7 | CID000125800 | |
| Drug | SK&F 82958 | 2.20e-10 | 19 | 208 | 7 | ctd:C071262 | |
| Drug | xanthine amine congener | 3.21e-10 | 64 | 208 | 10 | CID000005697 | |
| Drug | SQ22536 | CFTR DCN ADCY1 ADCY2 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 AKT1 NOS3 GUCY1B1 LRBA | 3.49e-10 | 135 | 208 | 13 | CID000005270 |
| Drug | AC1L1IZ2 | HSP90B1 MYH8 MYH10 MYO1A CFTR ADCY1 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 RAB3A MYO1B AGPS ARPC3 GSN LRBA YME1L1 | 4.37e-10 | 304 | 208 | 18 | CID000004795 |
| Drug | MDL-12330A | 4.41e-10 | 66 | 208 | 10 | CID000004024 | |
| Drug | reproterol | 5.01e-10 | 21 | 208 | 7 | CID000025654 | |
| Drug | GSK835726 | 7.29e-10 | 22 | 208 | 7 | CID005311268 | |
| Drug | AMP group | GPHN HSP90B1 ABCC4 EARS2 CFTR CGA DGKA DCN ADCY1 ADCY2 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 DST PURA AHCY AKT1 UQCRC2 NOS3 RET P2RX3 LRBA | 7.44e-10 | 579 | 208 | 24 | CID000000224 |
| Drug | AC1L1BJN | 8.80e-10 | 13 | 208 | 6 | CID000001467 | |
| Drug | sclareol glycol | 8.80e-10 | 13 | 208 | 6 | CID000091915 | |
| Drug | nantradol hydrochloride | 8.80e-10 | 13 | 208 | 6 | CID000047652 | |
| Drug | beta-CNA | 1.04e-09 | 23 | 208 | 7 | CID005486190 | |
| Drug | Scpb | 1.04e-09 | 23 | 208 | 7 | CID000123843 | |
| Drug | NAIN | 1.46e-09 | 24 | 208 | 7 | CID000195228 | |
| Drug | TL-99 | 1.46e-09 | 24 | 208 | 7 | CID000122132 | |
| Drug | trimetoquinol | 1.46e-09 | 24 | 208 | 7 | CID000005581 | |
| Drug | AC1L8VEV | 1.46e-09 | 24 | 208 | 7 | CID000433433 | |
| Drug | AC1MUNZL | 1.95e-09 | 56 | 208 | 9 | CID003643892 | |
| Drug | PD 81,723 | 2.01e-09 | 25 | 208 | 7 | CID000122028 | |
| Drug | octimibate | 2.01e-09 | 25 | 208 | 7 | CID000065676 | |
| Drug | butaprost | 2.39e-09 | 78 | 208 | 10 | CID005311035 | |
| Drug | Peptavlon | 2.39e-09 | 78 | 208 | 10 | CID000021701 | |
| Drug | SKF 75670 | 2.53e-09 | 15 | 208 | 6 | CID000173870 | |
| Drug | AC1L2AAS | 2.53e-09 | 15 | 208 | 6 | CID000068714 | |
| Drug | glibenclamide | ABCC4 ABCA1 CFTR DCN ADCY1 ADCY5 ABCA8 ADCY6 ADCY7 ADCY8 ADCY9 CLCC1 KCNJ13 NOS3 SLC26A9 GUCY1B1 SCARB1 LRBA YME1L1 | 2.58e-09 | 382 | 208 | 19 | CID000003488 |
| Drug | K-Cl | MYH8 MYH10 MYO1A EARS2 CFTR SRF DCN ADCY1 ADCY2 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 KCNJ13 NOS3 CALB1 POLD1 CAPG MYO1B GSN GUCY1B1 POLQ | 2.60e-09 | 567 | 208 | 23 | CID000004873 |
| Drug | metaproterenol | 2.73e-09 | 26 | 208 | 7 | CID000004086 | |
| Drug | 7B-forskolin | 2.73e-09 | 26 | 208 | 7 | CID000130638 | |
| Drug | AC1NIP3C | 3.13e-09 | 41 | 208 | 8 | CID004834553 | |
| Drug | Vasotocin | 3.15e-09 | 59 | 208 | 9 | CID000024774 | |
| Drug | SM-10906 | 3.65e-09 | 27 | 208 | 7 | CID006442261 | |
| Drug | BRL 37344 | 3.83e-09 | 42 | 208 | 8 | CID000002436 | |
| Drug | CGP 12177 | 3.83e-09 | 42 | 208 | 8 | CID000002687 | |
| Drug | prenalterol | 4.83e-09 | 28 | 208 | 7 | CID000042396 | |
| Drug | desacetylnantradol | 4.83e-09 | 28 | 208 | 7 | CID000125211 | |
| Drug | tetrahydrofurfuryl alcohol | 4.83e-09 | 28 | 208 | 7 | CID000007360 | |
| Drug | San 21009 | 6.16e-09 | 17 | 208 | 6 | CID000152662 | |
| Drug | U754 | 6.16e-09 | 17 | 208 | 6 | CID000062824 | |
| Drug | fentanyl isothiocyanate | 6.16e-09 | 17 | 208 | 6 | CID000084008 | |
| Drug | tolazoline | 6.32e-09 | 29 | 208 | 7 | CID000005504 | |
| Drug | adenosine analog | 6.65e-09 | 64 | 208 | 9 | CID000469074 | |
| Drug | clenbuterol | MYH8 MYH10 MYO1A RPS6KA2 ADCY1 ADCY2 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 MYO1B | 7.57e-09 | 142 | 208 | 12 | CID000002783 |
| Drug | betaxolol | 1.17e-08 | 48 | 208 | 8 | CID000002369 | |
| Drug | Neomigran | 1.17e-08 | 48 | 208 | 8 | CID000003066 | |
| Drug | NO-cAMP | 1.31e-08 | 69 | 208 | 9 | CID006426615 | |
| Drug | AC1L3XQA | 1.33e-08 | 19 | 208 | 6 | CID000124009 | |
| Drug | dopexamine | 1.33e-08 | 32 | 208 | 7 | CID000055483 | |
| Drug | 6,7-ADTN | 1.68e-08 | 33 | 208 | 7 | CID000003153 | |
| Drug | phosphonate analog | 1.68e-08 | 33 | 208 | 7 | CID000475766 | |
| Drug | N6-monobutyryl-cAMP | 1.68e-08 | 33 | 208 | 7 | CID000115029 | |
| Drug | sulprostone | 1.70e-08 | 71 | 208 | 9 | CID005312153 | |
| Drug | Dvdavp | 1.88e-08 | 20 | 208 | 6 | CID006441676 | |
| Drug | YM435 | 1.88e-08 | 20 | 208 | 6 | CID000132119 | |
| Drug | NSC97113 | 1.93e-08 | 51 | 208 | 8 | CID000001869 | |
| Drug | 6-fluoronorepinephrine | 2.62e-08 | 21 | 208 | 6 | CID000001862 | |
| Drug | indapamide | 2.64e-08 | 53 | 208 | 8 | CID000003702 | |
| Drug | Ts-I | 2.78e-08 | 75 | 208 | 9 | CID000445278 | |
| Drug | AC1L1DSZ | 3.20e-08 | 36 | 208 | 7 | CID000002494 | |
| Drug | chlorthalidone | 3.20e-08 | 36 | 208 | 7 | CID000002732 | |
| Drug | enprofylline | 3.20e-08 | 36 | 208 | 7 | CID000001676 | |
| Drug | 2-chloroadenosine | 3.34e-08 | 102 | 208 | 10 | CID000008974 | |
| Drug | practolol | 3.92e-08 | 37 | 208 | 7 | CID000004883 | |
| Drug | fenoterol | 4.13e-08 | 56 | 208 | 8 | CID000003343 | |
| Drug | 2g6p | 4.76e-08 | 38 | 208 | 7 | CID002740174 | |
| Drug | AC1L1XPX | 4.76e-08 | 38 | 208 | 7 | CID000011606 | |
| Drug | NSC-4928 | 5.49e-08 | 58 | 208 | 8 | CID000221086 | |
| Drug | trequinsin | 5.49e-08 | 58 | 208 | 8 | CID000005537 | |
| Drug | oxotremorine | 5.80e-08 | 108 | 208 | 10 | CID000004630 | |
| Drug | 2',3'-dideoxyadenosine | 6.14e-08 | 82 | 208 | 9 | CID000020039 | |
| Drug | DEPX | 6.35e-08 | 24 | 208 | 6 | CID000001328 | |
| Drug | dimaprit | 6.93e-08 | 40 | 208 | 7 | CID000003077 | |
| Drug | PNU-107859 | ADCY1 ADCY2 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 RAB3A RAB3B RAB3D PBRM1 LRBA | 7.35e-08 | 174 | 208 | 12 | CID004369084 |
| Drug | zaprinast | ABCC4 DCN ADCY1 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 NOS3 GUCY1B1 LRBA | 7.41e-08 | 141 | 208 | 11 | CID000005722 |
| Drug | AC1L9NB5 | 8.29e-08 | 25 | 208 | 6 | CID000449609 | |
| Drug | tiotidine | 8.29e-08 | 25 | 208 | 6 | CID000050287 | |
| Drug | manganese-ATP | 8.29e-08 | 25 | 208 | 6 | CID000124341 | |
| Drug | N-n-propylnorapomorphine | 8.29e-08 | 25 | 208 | 6 | CID000030137 | |
| Drug | AC1L1I54 | 8.29e-08 | 41 | 208 | 7 | CID000004426 | |
| Drug | N6-(phenylisopropyl)adenosine | 8.29e-08 | 41 | 208 | 7 | CID000034507 | |
| Drug | Benzamide | 9.33e-08 | 86 | 208 | 9 | CID000002331 | |
| Drug | AC1L1DXN | 9.33e-08 | 86 | 208 | 9 | CID000002552 | |
| Drug | 8-iso Misoprostol | 9.39e-08 | 62 | 208 | 8 | CID004183806 | |
| Drug | 8-phenyltheophylline | 9.39e-08 | 62 | 208 | 8 | CID000001922 | |
| Drug | OD-q | DCN ADCY1 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 AKT1 NOS3 GUCY1B2 GUCY1B1 LRBA | 1.00e-07 | 179 | 208 | 12 | CID000001456 |
| Drug | amrinone | 1.17e-07 | 43 | 208 | 7 | CID000003698 | |
| Drug | platinum | ABCC4 ERCC3 DDB1 ADCY1 ADCY2 ADCY5 ADCY6 ADCY7 ADCY8 ADCY9 MID1 SLC6A8 | 1.28e-07 | 183 | 208 | 12 | CID000023939 |
| Drug | RU 24926 | 1.36e-07 | 27 | 208 | 6 | CID000122203 | |
| Disease | Colorectal Carcinoma | ABCC4 ABCA1 CFTR SRC ABCA8 ADCY8 AKT1 UQCRC2 DNAH8 RALGDS POLD1 SYNE1 RBP3 MYO1B RET ZNF432 SNRNP200 EDRF1 | 1.97e-06 | 702 | 203 | 18 | C0009402 |
| Disease | Colorectal Neoplasms | 2.41e-05 | 277 | 203 | 10 | C0009404 | |
| Disease | Bipolar Disorder | NRG1 HSP90B1 RPS6KA2 ADCY2 ADCY8 CBLIF SORCS2 AKT1 DNAH8 NOS3 SYNE1 PBRM1 | 1.26e-04 | 477 | 203 | 12 | C0005586 |
| Disease | Cutaneous Melanoma | 1.80e-04 | 41 | 203 | 4 | C0151779 | |
| Disease | Cannabis Dependence | 2.03e-04 | 17 | 203 | 3 | C0006870 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 2.18e-04 | 43 | 203 | 4 | DOID:9261 (is_marker_for) | |
| Disease | Transitional cell carcinoma of bladder | 2.80e-04 | 4 | 203 | 2 | C0279680 | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 2.80e-04 | 4 | 203 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | oropharynx cancer | 2.83e-04 | 46 | 203 | 4 | EFO_1001931 | |
| Disease | familial hyperlipidemia (biomarker_via_orthology) | 2.87e-04 | 19 | 203 | 3 | DOID:1168 (biomarker_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.22e-04 | 195 | 203 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | bipolar I disorder | 4.47e-04 | 141 | 203 | 6 | EFO_0009963 | |
| Disease | Cerebellar Ataxia | 4.65e-04 | 5 | 203 | 2 | C0007758 | |
| Disease | follicular lymphoma (implicated_via_orthology) | 4.65e-04 | 5 | 203 | 2 | DOID:0050873 (implicated_via_orthology) | |
| Disease | attention function measurement | 5.77e-04 | 148 | 203 | 6 | EFO_0007636 | |
| Disease | xeroderma pigmentosum (implicated_via_orthology) | 6.94e-04 | 6 | 203 | 2 | DOID:0050427 (implicated_via_orthology) | |
| Disease | Familial erythrocytosis | 6.94e-04 | 6 | 203 | 2 | cv:C0152264 | |
| Disease | fibrinogen measurement, coronary artery disease | 7.11e-04 | 154 | 203 | 6 | EFO_0001645, EFO_0004623 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 7.42e-04 | 26 | 203 | 3 | DOID:234 (is_implicated_in) | |
| Disease | colorectal cancer (is_marker_for) | 7.86e-04 | 157 | 203 | 6 | DOID:9256 (is_marker_for) | |
| Disease | epilepsy (implicated_via_orthology) | 9.56e-04 | 163 | 203 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | lethal congenital contracture syndrome (is_implicated_in) | 9.67e-04 | 7 | 203 | 2 | DOID:0060558 (is_implicated_in) | |
| Disease | Ciliopathies | 1.00e-03 | 110 | 203 | 5 | C4277690 | |
| Disease | bipolar disorder (is_implicated_in) | 1.03e-03 | 29 | 203 | 3 | DOID:3312 (is_implicated_in) | |
| Disease | factor VIII measurement, coronary artery disease | 1.13e-03 | 113 | 203 | 5 | EFO_0001645, EFO_0004630 | |
| Disease | Marijuana Abuse | 1.14e-03 | 30 | 203 | 3 | C0024809 | |
| Disease | Drug habituation | 1.22e-03 | 115 | 203 | 5 | C0013170 | |
| Disease | Drug abuse | 1.22e-03 | 115 | 203 | 5 | C0013146 | |
| Disease | factor XI measurement, coronary artery disease | 1.22e-03 | 115 | 203 | 5 | EFO_0001645, EFO_0004694 | |
| Disease | Prescription Drug Abuse | 1.22e-03 | 115 | 203 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 1.22e-03 | 115 | 203 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 1.22e-03 | 115 | 203 | 5 | C0013222 | |
| Disease | Drug Dependence | 1.22e-03 | 115 | 203 | 5 | C1510472 | |
| Disease | Substance Dependence | 1.22e-03 | 115 | 203 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 1.22e-03 | 115 | 203 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.22e-03 | 115 | 203 | 5 | C0029231 | |
| Disease | Substance abuse problem | 1.27e-03 | 116 | 203 | 5 | C0740858 | |
| Disease | Leydig cell tumor (is_marker_for) | 1.28e-03 | 8 | 203 | 2 | DOID:2696 (is_marker_for) | |
| Disease | triacylglycerol 58:6 measurement | 1.28e-03 | 8 | 203 | 2 | EFO_0010440 | |
| Disease | pantothenate measurement | 1.28e-03 | 8 | 203 | 2 | EFO_0021034 | |
| Disease | Polycythemia | 1.28e-03 | 8 | 203 | 2 | C0032461 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 1.37e-03 | 118 | 203 | 5 | EFO_0001645, EFO_0004629 | |
| Disease | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis | 1.40e-03 | 70 | 203 | 4 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0001060, EFO_0002609, EFO_0003898, EFO_0005140, EFO_0006812, MONDO_0005147, MONDO_0007915, MONDO_0015517 | |
| Disease | coronary artery disease | ABCA1 CNPY4 CFTR TUB NEK9 ABCA8 SBK1 KCNJ13 NOS3 PID1 RAC1 FLT1 DNAH10 DYNC2H1 AP4E1 IGF2R GUCY1B1 SCARB1 | 1.59e-03 | 1194 | 203 | 18 | EFO_0001645 |
| Disease | liver cirrhosis (biomarker_via_orthology) | 1.64e-03 | 34 | 203 | 3 | DOID:5082 (biomarker_via_orthology) | |
| Disease | cystic fibrosis (implicated_via_orthology) | 1.64e-03 | 9 | 203 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Polycystic Kidney Disease | 1.64e-03 | 9 | 203 | 2 | C0085548 | |
| Disease | melanoma | 1.72e-03 | 248 | 203 | 7 | C0025202 | |
| Disease | colon cancer (is_implicated_in) | 1.94e-03 | 36 | 203 | 3 | DOID:219 (is_implicated_in) | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.96e-03 | 128 | 203 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.96e-03 | 128 | 203 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.96e-03 | 128 | 203 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.96e-03 | 128 | 203 | 5 | C1306837 | |
| Disease | hypertension (implicated_via_orthology) | 1.96e-03 | 128 | 203 | 5 | DOID:10763 (implicated_via_orthology) | |
| Disease | Renal Cell Carcinoma | 1.96e-03 | 128 | 203 | 5 | C0007134 | |
| Disease | Mental Depression | 1.96e-03 | 254 | 203 | 7 | C0011570 | |
| Disease | Cannabis Abuse | 2.04e-03 | 10 | 203 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 2.04e-03 | 10 | 203 | 2 | C0236735 | |
| Disease | triacylglycerol 54:1 measurement | 2.04e-03 | 10 | 203 | 2 | EFO_0010419 | |
| Disease | thrombosis (implicated_via_orthology) | 2.04e-03 | 10 | 203 | 2 | DOID:0060903 (implicated_via_orthology) | |
| Disease | Hashish Abuse | 2.04e-03 | 10 | 203 | 2 | C0018614 | |
| Disease | susceptibility to influenza measurement | 2.04e-03 | 10 | 203 | 2 | EFO_0803537 | |
| Disease | hip circumference | 2.47e-03 | 338 | 203 | 8 | EFO_0005093 | |
| Disease | Cardiomegaly | 2.50e-03 | 82 | 203 | 4 | C0018800 | |
| Disease | Cardiac Hypertrophy | 2.50e-03 | 82 | 203 | 4 | C1383860 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.80e-03 | 139 | 203 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Oligospermia | 2.97e-03 | 12 | 203 | 2 | C0028960 | |
| Disease | papillary thyroid carcinoma | 2.97e-03 | 12 | 203 | 2 | EFO_0000641 | |
| Disease | sialate O-acetylesterase measurement | 2.97e-03 | 12 | 203 | 2 | EFO_0803073 | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 2.97e-03 | 12 | 203 | 2 | DOID:3319 (is_marker_for) | |
| Disease | myocardial infarction | 3.06e-03 | 350 | 203 | 8 | EFO_0000612 | |
| Disease | Adenocarcinoma of lung (disorder) | 3.12e-03 | 206 | 203 | 6 | C0152013 | |
| Disease | Cardiotoxicity | 3.49e-03 | 13 | 203 | 2 | C0876994 | |
| Disease | colon carcinoma (is_marker_for) | 3.49e-03 | 13 | 203 | 2 | DOID:1520 (is_marker_for) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.67e-03 | 148 | 203 | 5 | C0279702 | |
| Disease | adipose tissue measurement | 3.68e-03 | 45 | 203 | 3 | EFO_0004764 | |
| Disease | diabetic retinopathy (biomarker_via_orthology) | 3.68e-03 | 45 | 203 | 3 | DOID:8947 (biomarker_via_orthology) | |
| Disease | Depressive disorder | 4.01e-03 | 289 | 203 | 7 | C0011581 | |
| Disease | Paroxysmal atrial fibrillation | 4.58e-03 | 156 | 203 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 4.58e-03 | 156 | 203 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 4.58e-03 | 156 | 203 | 5 | C2585653 | |
| Disease | periodontitis | 4.58e-03 | 223 | 203 | 6 | EFO_0000649 | |
| Disease | Aganglionosis, Colonic | 4.66e-03 | 15 | 203 | 2 | C0085758 | |
| Disease | Lymphoma, Follicular, Grade 2 | 4.66e-03 | 15 | 203 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 4.66e-03 | 15 | 203 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 4.66e-03 | 15 | 203 | 2 | C1956130 | |
| Disease | Lymphoma, Large-Cell, Follicular | 4.66e-03 | 15 | 203 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 4.66e-03 | 15 | 203 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 4.66e-03 | 15 | 203 | 2 | C0079758 | |
| Disease | Aganglionosis, Rectosigmoid Colon | 4.66e-03 | 15 | 203 | 2 | C1257840 | |
| Disease | thrombosis (is_implicated_in) | 4.66e-03 | 15 | 203 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | cholestasis (biomarker_via_orthology) | 4.68e-03 | 49 | 203 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | Fibrosis | 4.96e-03 | 50 | 203 | 3 | C0016059 | |
| Disease | Cirrhosis | 4.96e-03 | 50 | 203 | 3 | C1623038 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 5.00e-03 | 301 | 203 | 7 | DOID:684 (is_marker_for) | |
| Disease | Atrial Fibrillation | 5.09e-03 | 160 | 203 | 5 | C0004238 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 5.09e-03 | 160 | 203 | 5 | DOID:5844 (biomarker_via_orthology) | |
| Disease | neurotic disorder | 5.28e-03 | 101 | 203 | 4 | EFO_0004257 | |
| Disease | Diabetic Angiopathies | 5.30e-03 | 16 | 203 | 2 | C0011875 | |
| Disease | Microangiopathy, Diabetic | 5.30e-03 | 16 | 203 | 2 | C0025945 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TMNEFEYLKLLGKGT | 146 | P31749 | |
| EKIKTIGSTYMAVSG | 1031 | P40145 | |
| RYAKGQSQTMATLKG | 111 | Q8N129 | |
| ATYKVKDSSVGKMIG | 36 | Q13015 | |
| SGGQMTVKDLTAKYT | 1206 | P13569 | |
| KGALYKTLVSEGMLT | 616 | Q8WY36 | |
| VSQRGKVYSTKAGMG | 466 | Q9H7T0 | |
| YSVGGLLQEVMKFAK | 816 | Q5JQC9 | |
| GKDSYLALVDKNIMG | 676 | Q96Q42 | |
| AISVGFTKAKGYSTM | 1066 | O14514 | |
| MKLTDVGIATLAKGY | 2086 | Q86TB3 | |
| GKSSRGLKIYAMEIS | 591 | Q8IUX7 | |
| QLEKIKTIGSTYMAA | 1026 | O43306 | |
| DTKKKMYSSILVVGG | 526 | Q9H981 | |
| ESYVGKEAQSKRGML | 51 | Q9BYX7 | |
| DLLSGMDGKGSYQVK | 1306 | O95477 | |
| MVEYSLSKGKGNKVS | 561 | O75534 | |
| VNTGFLMSSYKVEAK | 91 | Q7Z6K5 | |
| GVEKIKTIGSTYMAA | 926 | P51828 | |
| KIKTIGSTYMAASGL | 1121 | O95622 | |
| MYSNVIGTVTSGKRK | 1 | P01008 | |
| MYRSAKSGLKGVQSL | 451 | Q8IV53 | |
| KSGLKGVQSLLMYKD | 456 | Q8IV53 | |
| TGLESVMGKYQLLTS | 676 | Q8TAM1 | |
| MDGVNLSTEVVYKKG | 366 | Q8WUJ3 | |
| ISSMEKKLNGGLYCT | 481 | Q9BXF3 | |
| RMIKENSSGYKDLTG | 231 | Q9UPM8 | |
| GSSSDTYLFKKGVMK | 336 | Q6ZSC3 | |
| NKLKAGYLMSVESSE | 376 | P22695 | |
| YMFKILIIGNSSVGK | 21 | P20336 | |
| YMFKLLIIGNSSVGK | 21 | P20337 | |
| YMFKLLLIGNSSVGK | 21 | O95716 | |
| MSLNKDGSYTGFIKV | 156 | Q9NS23 | |
| TDKLKMTLNSNGIYT | 66 | Q86WH2 | |
| QGLAMAKEIGAVKYL | 141 | P63000 | |
| YQEGILSMKVTRKGS | 261 | Q52LD8 | |
| YTSQICKGMEYLGTK | 956 | O60674 | |
| SGGVSMGEKDYLKQV | 571 | Q9NQX3 | |
| DSGEYMCKVISKLGN | 106 | Q02297 | |
| ASENSKSAGYVIGMK | 416 | Q9Y6F1 | |
| KMQYVGGEAVIALSK | 1006 | Q7Z5J8 | |
| DAETLYKAMKGIGTN | 26 | P13928 | |
| YKAMKGIGTNEQAII | 31 | P13928 | |
| SYMGKSLKDLGKNSE | 1001 | Q96KG7 | |
| LVVTKYKMGGDIANR | 16 | Q9UQ80 | |
| KGSSAVGLTAYVMKD | 536 | P33991 | |
| KKSVSYMVSKEGGGN | 166 | Q96PD6 | |
| LSEKKTISYQGCMGQ | 86 | P58180 | |
| SSKDQGKMVSLFYGI | 266 | P58173 | |
| GSKRKINMSGYILFS | 1376 | Q86U86 | |
| TGMEIKEGKQSYRQK | 111 | Q2VYF4 | |
| AKMGDASTQLSSYVK | 246 | Q2VYF4 | |
| KLGAEMVINTSGKYG | 431 | Q17RR3 | |
| ATVSGYDIMKSKSNP | 981 | Q6WCQ1 | |
| SASMSGAGRKTIYKD | 1406 | Q9NZR2 | |
| AGLALKYGVTMEQIK | 51 | Q96S90 | |
| GLAKKLNSEYSMAET | 196 | Q8TD19 | |
| EVTKGNGYLQKMVSI | 466 | Q9NPP4 | |
| KMTASSIIGENKNYL | 976 | Q9Y6X6 | |
| GKTEASKLVMSYVAA | 106 | Q9UBC5 | |
| LFLDKMGSLQKGNYS | 656 | Q3B7T1 | |
| SDKSAMVTKSLEYLG | 906 | Q6ZRQ5 | |
| GKKVFSAGLQLTYGM | 931 | Q6ZRQ5 | |
| MIGDGTVELKKYQSK | 3671 | Q03001 | |
| DTETNLAGMYGKVRK | 661 | Q8TBA6 | |
| ITKMSSANVYLESKG | 226 | Q8N3F9 | |
| ISGKYLAGALEKMVN | 3496 | Q15751 | |
| DVRGAGTKSKIYLVM | 306 | Q8IVV2 | |
| SYTSVFKDLMGKSNV | 6266 | Q5CZC0 | |
| LLAYSGVQSKKLTAM | 331 | Q9BPX6 | |
| YQKFVKMATLTSGGE | 106 | Q5T3I0 | |
| DTVVGLYQKSAMKTL | 606 | P13535 | |
| CKVTYLGKVSTTGMQ | 91 | Q7Z2X4 | |
| YRGDAQGKKVMSILV | 381 | Q9ULD0 | |
| SLKTVQGKKGVYMTD | 26 | A8MUH7 | |
| IENGAFQGMKKLSYI | 191 | P07585 | |
| GEQGTAKTVMVKAYL | 2456 | Q96JB1 | |
| GAIEMGQIYTKLKNA | 661 | P23743 | |
| IEYKTSKEGSVMGVT | 516 | Q9P265 | |
| SLLTRGSKGEYQIKM | 301 | O60928 | |
| KSEGIRVQALKAMGY | 731 | P50851 | |
| VYSQDLGEMTKLNSK | 1431 | Q8NG31 | |
| KVETVGDKYMTVSGL | 471 | Q02153 | |
| KAKYSMGITSLLANG | 261 | Q5XXA6 | |
| KYSSGSMEQGKVSSV | 261 | Q8NGG8 | |
| TSELFYEGKLMASGK | 876 | P42694 | |
| YIGISIMKITSAKGR | 221 | Q8NGI8 | |
| KGNMSGNFTYIIDKL | 186 | P48551 | |
| GTVMAKRVKATILYG | 511 | P29474 | |
| MATNYLSGKKSISFV | 81 | Q8NHA4 | |
| AKSYNRVTVMGGFKV | 86 | P01215 | |
| LKDGKMVQKGTYTEF | 606 | O15439 | |
| MVQKGTYTEFLKSGI | 611 | O15439 | |
| IMKAQAYQTGKDIST | 661 | P14625 | |
| YSLMEQKLGKSGHLQ | 196 | P47804 | |
| GSSSKIYLLAGSMVQ | 2461 | Q8NCM8 | |
| YVTKVMSKGAADAIA | 251 | O14531 | |
| EKIKTIGSTYMAATG | 936 | Q08462 | |
| KGKGDLKTYFVNTEM | 1066 | Q08462 | |
| VSVKGKGEMLTYFLE | 1041 | Q08828 | |
| NYMGSVKESLDSKAT | 111 | Q9UKF2 | |
| ILKYKPSGNATDMST | 71 | Q8WYA0 | |
| SMKIKDNGIIGDIYS | 211 | P27352 | |
| DAETLYKAMKGIGTN | 26 | Q5VT79 | |
| YKAMKGIGTNEQAII | 31 | Q5VT79 | |
| KMGQKEYSIGTGSTK | 136 | P19525 | |
| NSKSQGEKEMYTLGI | 86 | O15145 | |
| TLKKGLGEDMYSGIT | 251 | Q9H1K4 | |
| ALKTMASQGGPKYTL | 721 | Q96JB2 | |
| KGFVKMALQTGAYLV | 206 | Q6ZPD8 | |
| VKVGNSIYDSSMKLV | 296 | O75417 | |
| KTQLYGFLKEMGSEV | 756 | Q8IWJ2 | |
| ITTYKKNIMALSDGG | 231 | P05937 | |
| KIKTIGATYMAASGL | 1106 | O60503 | |
| KLGSYKINGRTKAMV | 286 | Q9GZT9 | |
| GKDGKQYESVLMVSI | 31 | P13232 | |
| GNMYKSILVTSQDKA | 811 | Q12967 | |
| QLLKEAGYTTHMVGK | 131 | P15848 | |
| ATMKATSVKGYTGAN | 71 | Q5VTH9 | |
| SDTKDYFMSKTLGIG | 516 | Q8NA03 | |
| LGMTSTTAKGDVYAK | 746 | Q9ULL0 | |
| KNNMVGVVIGYSGSK | 56 | Q86TM3 | |
| LYKVSDATGQMNLTK | 251 | P40121 | |
| KLAKLYKVSNGAGTM | 296 | P06396 | |
| YKVSNGAGTMSVSLV | 301 | P06396 | |
| SAEMKIAIYLSKSGI | 616 | Q9H583 | |
| ADVLGSKVGMSQEKY | 891 | Q6PJP8 | |
| GIMQFIKLCTVSYGK | 151 | P19447 | |
| LATLKKAVSTTGYDM | 136 | P60008 | |
| TSKLGTGNRMYHTKE | 116 | Q8IY37 | |
| GKAMVINYTVTLKGL | 3541 | Q8IVF4 | |
| LTKLTEKQAQYLGMS | 406 | P23526 | |
| KVDLVVYKGTGTKMA | 66 | Q52WX2 | |
| VYKGTGTKMALKFVN | 71 | Q52WX2 | |
| AFTLKQKLVNMGGYT | 491 | Q68D06 | |
| IISAAKGVAAYMKSE | 926 | P28340 | |
| VKGAVYSMVEFNGKL | 866 | Q16531 | |
| NSSFTKVITLMGQKY | 241 | Q8N3J2 | |
| SAYKTKKGMFRTVGQ | 641 | P35580 | |
| IMGVSKYGIKVSTSD | 111 | O14713 | |
| QGSLLGTLKTFKMEY | 276 | Q2NKX8 | |
| YNLQVKTEMDKLSSG | 11 | Q8NGG3 | |
| VTKVKGSGLYANRVM | 61 | P56373 | |
| KYSSGSMEQGKVSSV | 261 | Q96RD0 | |
| ISKMSLANIYLESKG | 216 | O60478 | |
| KLTYENGLLKMNFTG | 1301 | P11717 | |
| GVKLNKNVMTIITGY | 786 | A6NKG5 | |
| LIGIKDMYAKVSGSI | 326 | P82675 | |
| YAIGKDVQAMKAVVG | 426 | P21281 | |
| TEYMSKGSLLDFLKG | 341 | P12931 | |
| GKKGSKNNISVYMTL | 556 | Q96N64 | |
| LAMIKGIQSSGKIIY | 241 | Q9H2J7 | |
| TMLALASSQGDGLYK | 731 | Q68CJ6 | |
| SGSAYDKESMAIIKL | 306 | Q9HB90 | |
| LSLYLCQTMKVGTKG | 181 | Q8TBZ9 | |
| AFMINGLKSTGKVIY | 281 | Q9GZN6 | |
| KGYMKLLGECSSSID | 8371 | Q8NF91 | |
| VKVGMFSSGELIYKK | 391 | Q8N9U0 | |
| DLMGIKALAKLSSTY | 676 | Q7LBE3 | |
| VSKKTNYLVMGRDSG | 441 | P35251 | |
| CKGILQKAETLYTMG | 81 | Q96NG3 | |
| AGATNIDLKLKDYGM | 111 | O95744 | |
| AGMFGKETYVKLLSA | 1631 | P58107 | |
| EVKGKGRMTTYFLIQ | 551 | O75343 | |
| SIYGALKKIMRTEGF | 86 | Q9NYZ2 | |
| IDGKVMTLITYNKGR | 461 | Q96PQ0 | |
| KEMNGKKGVSILSIY | 451 | Q149N8 | |
| AFTLKQKLVNMGGYT | 491 | Q7Z7L1 | |
| SLYMKSVAGIGQTGK | 391 | Q8WTV0 | |
| TAGYKSLLKITMTQS | 1076 | Q9NT68 | |
| MAKKSAENGIYSVSG | 1 | P48029 | |
| YNEKGGMALALAVTK | 156 | P10155 | |
| KLSEGLEGTKYSNVM | 471 | Q5JPH6 | |
| TGIMKKAYELSTLTG | 166 | P11831 | |
| KNIKMLSSYTDNGIV | 1441 | Q9UK61 | |
| TKGSVTIYNNKLSEM | 536 | O94911 | |
| TRASGMKKNIYGNIE | 316 | O00116 | |
| ISDVGFGMLKSVKEY | 631 | O00116 | |
| SGTMRKSQAKYGISG | 36 | Q96S66 | |
| VKGTVLTIKSYGMLV | 456 | Q14690 | |
| LTIKSYGMLVKVGEQ | 461 | Q14690 | |
| SKGMLKNSTAALYID | 1201 | Q8IZQ1 | |
| NYASAELGAKMATKL | 951 | P10745 | |
| RGAVLTTTQYGKMKG | 266 | Q9UHK0 | |
| GKYLDGKAIMVAQTI | 71 | Q8N7X1 | |
| SRLQLVMKSGKYVLG | 16 | P62888 | |
| SSTKLVLVNMVYFKG | 171 | Q9UIV8 | |
| KYTGNIIKGVINMGS | 161 | O15270 | |
| KVGIKRYSLSMGSEV | 156 | A7XYQ1 | |
| NNEAKLGYSMTRGKI | 256 | Q5T0D9 | |
| GTKYIFMVKAINQAG | 456 | O15344 | |
| LGYRVMSKTKILATG | 426 | O75191 | |
| SQSYDIGKMDKKSTG | 246 | Q8IYF3 | |
| AAGYKSVLKITMTQS | 1011 | Q9P273 | |
| KSSIQQKTDLMGFGY | 1021 | Q9HCK4 | |
| MAGKKNVLSSLAVYA | 1 | Q9UHR5 | |
| LKGRAGYTTVAVKML | 746 | P07949 | |
| GYTTVAVKMLKENAS | 751 | P07949 | |
| EKLGVMTYSDTGKLS | 696 | Q96TA2 | |
| INKMKGYTLLSEGID | 81 | O75643 | |
| KFLGTKYLEVTLSGM | 471 | Q96NZ8 | |
| MTGRYSGLKAKIQEV | 986 | O95789 | |
| SMGYQVSKPDALSKL | 46 | O94892 | |
| IRSAMSKLIKGSSYG | 391 | Q9BY10 | |
| AVVKGIQSSGKVMYF | 241 | Q9H1V8 | |
| DGSNTLSVSYKKGRM | 646 | Q9H1V8 | |
| SALKLYSQDKTGMVD | 601 | O94901 | |
| KTSDSTKMRIYLGQL | 301 | Q9H7L9 | |
| GATASEYKALMTELK | 866 | P17948 | |
| ARVVKDMATGKSKGY | 126 | Q01085 | |
| YTLKEAELKMGSSLG | 816 | Q9NVE5 | |
| MVSFIKGGIKVRNSY | 181 | Q5SRH9 | |
| GSNKYGVFMRVSEVK | 236 | Q00577 | |
| DSYIGKLRSNLMGTK | 326 | P50607 | |
| VMKTRLAVGKTGQYS | 311 | Q6NUK1 | |
| KGDVVKIYTKMSANG | 811 | Q9UKW4 | |
| VRKVKGSDAGQLYAM | 76 | Q15349 | |
| GSDAGQLYAMKVLKK | 81 | Q15349 | |
| GAGKTEASKLVMSYV | 111 | O43795 | |
| MAKNILGSDSKTTYI | 2811 | Q9NR99 | |
| NGIGTNLVKKAIYAM | 296 | Q147X3 | |
| KGQMAYIKLEDRTSG | 51 | Q9NVZ3 |